nvcr-10q_20170630.htm

Large accelerated filer

Accelerated filer

Non-accelerated filer

☐ (Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

0001564590-17-014164.txt : 20170727 0001564590-17-014164.hdr.sgml : 20170727 20170727061618 ACCESSION NUMBER: 0001564590-17-014164 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170727 DATE AS OF CHANGE: 20170727 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novocure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 17984322 BUSINESS ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE 10-Q 1 nvcr-10q_20170630.htm 10-Q nvcr-10q_20170630.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2017

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-37565

NovoCure Limited

(Exact Name of Registrant as Specified in Its Charter)

Jersey		98-1057807
(State or Other Jurisdiction of		(I.R.S. Employer
Incorporation or Organization)		Identification No.)

Le Masurier House

La Rue Le Masurier

St. Helier, Jersey JE2 4YE

(Address of principal executive offices)

+44 (0) 15 3475 6700

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name, Former Address and Former Fiscal Year, If Changed Since Last Report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒.

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

Class		Outstanding as of July 20, 2017
Ordinary shares, no par value		89,002,575 Shares

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

In addition to historical facts or statements of current condition, this report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements contained in this report are based on our current plans, expectations, hopes, beliefs, intentions or strategies concerning future developments and their impact on us. Forward-looking statements contained in this report constitute our expectations or forecasts of future events as of the date this report was filed with the Securities and Exchange Commission and are not statements of historical fact. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Such statements may include words such as “anticipate,” “will,” “estimate,” “expect,” “project,” “intend,” “should,” “plan,” “believe,” “hope,” and other words and terms of similar meaning in connection with any discussion of, among other things, future operating or financial performance, strategic initiatives and business strategies, regulatory or competitive environments, our intellectual property and delivery system research and development. In particular, these forward-looking statements include, among others, statements about:

•

our research and development, clinical trial and commercialization activities and projected expenditures;

•

the further commercialization of Optune®, our first Tumor Treating Fields (“TTFields”) delivery system, and our other TTFields delivery system candidates;

•

our business strategies and the expansion of our sales and marketing efforts in the United States and in other countries;

•

the market acceptance of Optune and our other TTFields delivery systems by patients, physicians, third-party payers and others in the healthcare and scientific community;

•

our plans to pursue the use of TTFields for the treatment of other solid tumor cancers;

•

our estimates regarding revenues, expenses, capital requirements and needs for additional financing;

•

our ability to obtain regulatory approvals for additional indications and any future TTFields delivery systems;

•

our ability to acquire the supplies needed to manufacture our TTFields delivery systems from third-party suppliers;

•

our ability to manufacture adequate supply;

•

our ability to secure adequate coverage from third-party payers to reimburse us for Optune or future TTFields delivery systems;

•

our ability to maintain and develop our intellectual property position;

•

our cash needs;

•

our ongoing legal proceedings and tax audits; and

•

our prospects, financial condition and results of operations.

These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects fro m those projected in these forward-looking statements. Factors which may cause such differences to occur include those risks and uncertainties set forth under Part I, Item 1A., “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016, as well as other risks and uncertainties set forth from time to time in the reports we file with the U.S. Securities and Exchange Commission. We do not intend to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

TRADEMARKS

This Quarterly Report on Form 10-Q includes trademarks of NovoCure Limited and other persons. All trademarks or trade names referred to herein are the property of their respective owners.

NovoCure Limited

Quarterly Report on Form 10-Q

TABLE OF CONTENTS

			Page
Cautionary Note Regarding Forward Looking Statements			ii
Trademarks			ii

PART I—FINANCIAL INFORMATION

Item 1.	Financial Statements		2
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		12
Item 4.	Controls and Procedures		20

PART II—OTHER INFORMATION

Item 1.	Legal Proceedings		21
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		21
Item 6.	Exhibits		22

	Signatures	23

- 1 -

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

NOVOCURE LIMITED AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands

	June 30,		December 31,
	2017		2016
	Unaudited		Audited
ASSETS

CURRENT ASSETS:
Cash and cash equivalents	$	80,190	$	99,780
Short-term investments		104,186		119,854
Restricted cash		1,537		267
Trade receivables		13,888		6,339
Receivables and prepaid expenses		11,544		10,084
Inventories		25,147		25,549
Total current assets		236,492		261,873

LONG-TERM ASSETS:
Property and equipment, net		9,621		9,812
Field equipment, net		9,061		8,808
Severance pay fund		102		88
Other long-term assets		1,766		1,500
Total long-term assets		20,550		20,208

TOTAL ASSETS	$	257,042	$	282,081

The accompanying notes are an integral part of these unaudited consolidated financial statements.

- 2 -

NOVOCURE LIMITED AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands (except share data)

	June 30,			December 31,
	2017			2016
	Unaudited			Audited
LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:
Trade payables	$	13,161		$	18,356
Other payables and accrued expenses		22,010			18,526
Total current liabilities		35,171			36,882

LONG-TERM LIABILITIES:
Long-term loan, net of discount and issuance costs		96,765			96,231
Employee benefit liabilities		2,679			2,590
Other long-term liabilities		4,882			4,033
Total long-term liabilities		104,326			102,854

TOTAL LIABILITIES		139,497			139,736

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' EQUITY:
Share capital -		-			-
Ordinary shares no par value, unlimited shares authorized; issued and outstanding: 88,630,205 shares and 87,066,446 shares at June 30, 2017 (unaudited) and December 31, 2016, respectively
Additional paid-in capital		679,099			664,154
Accumulated other comprehensive loss		(1,739	)		(1,883	)
Accumulated deficit		(559,815	)		(519,926	)
Total shareholders' equity		117,545			142,345

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$	257,042		$	282,081

The accompanying notes are an integral part of these unaudited consolidated financial statements.

- 3 -

NOVOCURE LIMITED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

U.S. dollars in thousands (except share and per share data)

	Three months ended June 30,						Six months ended June 30,						Year ended December 31,
	2017			2016			2017			2016			2016
	Unaudited						Unaudited						Audited
Net revenues	$	38,376		$	17,919		$	73,256		$	30,972		$	82,888
Cost of revenues		13,152			9,797			24,816			17,779			39,870
Impairment of field equipment		-			6,412			-			6,412			6,412

Gross profit		25,224			1,710			48,440			6,781			36,606

Operating costs and expenses:
Research, development and clinical trials		9,371			11,318			18,782			22,763			41,467
Sales and marketing		16,360			14,598			31,116			27,906			59,449
General and administrative		15,023			13,031			27,445			25,287			51,007

Total operating costs and expenses		40,754			38,947			77,343			75,956			151,923

Operating loss		(15,530	)		(37,237	)		(28,903	)		(69,175	)		(115,317	)
Financial expenses, net		(2,183	)		(555	)		(4,629	)		(1,104	)		(6,147	)

Loss before income tax expense		(17,713	)		(37,792	)		(33,532	)		(70,279	)		(121,464	)
Income tax expense		3,461			2,820			5,687			5,770			10,381

Net loss	$	(21,174	)	$	(40,612	)	$	(39,219	)	$	(76,049	)	$	(131,845	)

Basic and diluted net loss per ordinary share	$	(0.24	)	$	(0.48	)	$	(0.45	)	$	(0.90	)	$	(1.54	)

Weighted average number of ordinary shares used in computing basic and diluted net loss per share		88,218,868			85,274,683			87,835,926			84,843,028			85,558,448

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

U.S. dollars in thousands

	Three months ended June 30,						Six months ended June 30,						Year ended December 31,
	2017			2016			2017			2016			2016
	Unaudited						Unaudited						Audited
Net loss	$	(21,174	)	$	(40,612	)	$	(39,219	)	$	(76,049	)	$	(131,845	)
Other comprehensive income (loss), net of tax :
Change in foreign currency translation adjustments		1			56			10			56			10
Pension benefit plan		183			235			134			(235	)		(388	)
Total comprehensive loss	$	(20,990	)	$	(40,321	)	$	(39,075	)		(76,228	)	$	(132,223	)

The accompanying notes are an integral part of these unaudited consolidated financial statements.

- 4 -

NOVOCURE LIMITED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

U.S. dollars in thousands (except share data)

	Ordinary shares		Additional paid-in		Accumulated other comprehensive			Accumulated			Total shareholders'
	Shares		capital		loss			deficit			equity

Balance as of December 31, 2015 (audited)		83,778,581	$	640,406	$	(1,505	)	$	(388,081	)	$	250,820
Share-based compensation to employees		-		21,441		-			-			21,441
Exercise of options and warrants		3,195,477		993		-			-			993
Issuance of shares in connection with employee stock purchase plan		92,388		616		-			-			616
Tax benefit from share-based award activity		-		698		-			-			698
Other comprehensive loss, net of tax benefit of $38		-		-		(378	)		-			(378	)
Net loss		-		-		-			(131,845	)		(131,845	)
Balance as of December 31, 2016 (audited)		87,066,446	$	664,154	$	(1,883	)	$	(519,926	)	$	142,345

Share-based compensation to employees		-		12,131		-			-			12,131
Exercise of options and warrants		1,446,792		1,363		-			-			1,363
Cumulative effect adjustment resulting from ASU 2016-09 adoption (see Note 1)		-		670		-			(670	)		-
Issuance of shares in connection with employee stock purchase plan		116,967		781		-			-			781
Other comprehensive loss, net of tax benefit of $29		-		-		144			-			144
Net loss		-		-		-			(39,219	)		(39,219	)
Balance as of June 30, 2017 (unaudited)		88,630,205	$	679,099	$	(1,739	)	$	(559,815	)	$	117,545

The accompanying notes are an integral part of these unaudited consolidated financial statements.

- 5 -

NOVOCURE LIMITED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

U.S. dollars in thousands

	Three months ended June 30,						Six months ended June 30,						Year ended December 31,
	2017			2016			2017			2016			2016
	Unaudited						Unaudited						Audited
Cash flows from operating activities:
Net loss	$	(21,174	)	$	(40,612	)	$	(39,219	)	$	(76,049	)	$	(131,845	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		1,811			1,407			3,471			2,510			5,652
Asset write-downs and impairment of field equipment		59			6,425			134			6,430			6,446
Increase in accrued interest expense		-			(637	)		-			-			-
Share-based compensation to employees		7,570			5,637			12,131			11,093			22,139
Excess tax benefits from share-based award activity		-			-			-			-			(698	)
Increase in trade receivables		(2,064	)		-			(7,550	)		-			(6,339	)
Amortization of discount (premium)		103			(39	)		209			(56	)		155
Decrease (increase) in receivables and prepaid expenses		3,354			(1,672	)		(1,461	)		(2,208	)		243
Decrease (Increase) in inventories		803			(4,769	)		403			(7,621	)		(11,955	)
Increase in other long-term assets		(38	)		(111	)		(294	)		(278	)		(692	)
Increase (decrease) in trade payables		(1,638	)		2,321			(5,195	)		4,144			1,601
Increase in other payables and accrued expenses		4,888			2,399			3,478			756			6,647
Increase in employee benefit liabilities, net		130			32			239			270			97
Increase in other long-term liabilities		321			225			871			638			957
Net cash used in operating activities	$	(5,875	)	$	(29,394	)	$	(32,783	)	$	(60,371	)	$	(107,592	)

Cash flows from investing activities:
Purchase of property and equipment	$	(376	)	$	(2,338	)	$	(1,407	)	$	(3,340	)	$	(5,674	)
Purchase of field equipment		(859	)		(4,274	)		(2,261	)		(6,100	)		(11,990	)
increase in restricted cash		(1	)		(13	)		(1,269	)		(12	)		(180	)
Proceeds from maturity of short-term investments		60,000			-			120,000			150,000			270,000
Purchase of short-term investments		(59,352	)		-			(104,006	)		(119,728	)		(239,341	)
Net cash provided by (used in) investing activities	$	(588	)	$	(6,625	)	$	11,057		$	20,820		$	12,815

Cash flows from financing activities:
Proceeds from issuance of shares, net	$	781		$	-		$	781		$	-		$	616
Proceeds from long-term loan, net		19			17			19			17			72,887
Excess tax benefits from share-based award activity		-			-			-			-			698
Repayment of other long-term loan		(19	)		(19	)		(37	)		(35	)		(70	)
Exercise of options and warrants		1,286			904			1,363			961			993
Net cash provided by financing activities	$	2,067		$	902		$	2,126		$	943		$	75,124

Effect of exchange rate changes on cash and cash equivalents	$	(1	)	$	56		$	10		$	56		$	10

Decrease in cash and cash equivalents		(4,397	)		(35,061	)		(19,590	)		(38,552	)		(19,643	)
Cash and cash equivalents at the beginning of the period		84,587			115,932			99,780			119,423			119,423

Cash and cash equivalents at the end of the period	$	80,190		$	80,871		$	80,190		$	80,871		$	99,780

Supplemental cash flow activities:
Cash paid during the period for:
Income taxes	$	1,500		$	1,587		$	4,902		$	3,169		$	9,447
Interest	$	2,533		$	1,269		$	5,041		$	1,933		$	6,595

The accompanying notes are an integral part of these unaudited consolidated financial statements.

- 6 -

NOVOCURE LIMITED AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share data)

NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION

Organization. NovoCure Limited (including its consolidated subsidiaries, the “Company”) was incorporated in the Bailiwick of Jersey and is principally engaged in the development, manufacture and commercialization of Tumor Treating Fields (“TTFields”) for the treatment of solid tumors. The Company has regulatory approvals and clearances in certain countries for Optune, its first TTFields delivery system, to treat adult patients with glioblastoma (“GBM”).

Financial statement preparation. The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries, and intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. These consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “2016 10-K”) filed with the Securities and Exchange Commission (the “SEC”) on February 23, 2017.

The significant accounting policies applied in the audited annual consolidated financial statements of the Company as disclosed in the 2016 10-K are applied consistently in these unaudited interim consolidated financial statements, except as noted below:

Recently Adopted Accounting Pronouncements. In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendments in ASU 2016-09 affect all entities that issue share-based payment awards to their employees and involve multiple aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted ASU 2016-09 during the quarter ended March 31, 2017, at which time it changed its accounting policy to account for forfeitures as they occur. The change was applied on a modified retrospective basis with a cumulative effect adjustment to accumulated deficit of $670 as of January 1, 2017. In addition, excess tax benefits for share-based payments are now presented as an operating activity in the statements of cash flows rather than financing activity. The changes have been applied prospectively in accordance with the ASU and prior periods have not been adjusted.

Recent Accounting Pronouncements. In May 2014, FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) (ASU 2014-09), which amends the existing accounting standards for revenue recognition. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delays the effective date of ASU 2014-09 by one year. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. The new revenue recognition standard will be effective in the first quarter of 2018, with the option to adopt it in the first quarter of 2017. The Company currently anticipates adopting the new standard effective January 1, 2018. The new standard also permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective method). The Company currently anticipates adopting the standard using the modified retrospective method. While the Company is still in the process of completing its assessment on the impact this guidance will have on its consolidated financial statements and related disclosures, the Company expects that the most significant impact relates to the accounting for revenue transactions whereby there is variable consideration.

In April 2016, FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. ASU 2016-10 covers two specific topics: performance obligations and licensing. This amendment includes guidance on immaterial promised goods or services, shipping or handling activities, separately identifiable performance obligations, functional or symbolic intellectual property licenses, sales-based and usage-based royalties, license restrictions (time, use, geographical) and licensing renewals. In addition, in May 2016, FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, which is intended to not change the core principle of the guidance in Topic 606, but rather affect only the narrow aspects of Topic 606 by reducing the potential for diversity in practice at initial application and by reducing the cost and complexity of applying Topic 606 both at transition and on an ongoing basis. The Company is currently evaluating the impact of the adoption of both revenue standards on its consolidated financial statements.

- 7 -

In February 2016, FASB issued ASU 2016-02-Leases (ASC 842), which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of their classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 supersedes the previous leases standard, ASC 840. The standard is effective on January 1, 2019, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements.

In May 2017, FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting. ASU 2017-09 provides clarification on when modification accounting should be used for changes to the terms or conditions of a share-based payment award. This ASU does not change the accounting for modifications but clarifies that modification accounting guidance should only be applied if there is a change to the value, vesting conditions, or award classification and would not be required if the changes are considered non-substantive. The Company is evaluating the impact of ASU 2017-09.

NOTE 2: SHORT-TERM INVESTMENTS

The Company invests in marketable U.S. Treasury Bills (“T-bills”) that are classified as held-to-maturity securities. The amortized cost and recorded basis of the T-bills are presented as short-term investments in the amount of $104,186 and $119,854 as of June 30, 2017 and December 31, 2016, respectively, and their estimated fair value as of June 30, 2017 and December 31, 2016 was $104,106 and $119,825, respectively.

NOTE 3: INVENTORIES

Inventories are stated at the lower of cost or market. The weighted average methodology is applied to determine cost. As of June 30, 2017 and December 31, 2016, the Company’s inventories were composed of:

	June 30,		December 31,
	2017		2016
	Unaudited		Audited
Raw materials	$	5,423	$	5,243
Work in progress		10,971		8,292
Finished products		8,753		12,014
Total	$	25,147	$	25,549

NOTE 4: COMMITMENTS AND CONTINGENT LIABILITIES

The facilities of the Company are leased under various operating lease agreements for periods ending no later than 2024. The Company also leases motor vehicles under various operating leases, which expire on various dates, the latest of which is in 2020.

As of June 30, 2017 and December 31, 2016, the Company pledged bank deposits of $1,051 and $807, respectively, to cover bank guarantees in respect of its leases of operating facilities and obtained guarantees by the bank for the fulfillment of the Company’s lease and other contractual commitments of $1,214 and $955, respectively.

In January 2017, two putative class action lawsuits were filed against the Company, its directors and certain of its officers, as well as the underwriters in the Company’s October 2015 initial public offering. The complaints, which purport to be brought on behalf of a class of persons and/or entities who purchased or otherwise acquired ordinary shares of the Company pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s initial public offering, allege material misstatements and/or omissions in the Company’s initial public offering materials in alleged violation of the federal securities laws and seek compensatory damages, among other remedies. The two actions have been consolidated and the plaintiffs filed a consolidated amended complaint on May 31, 2017. The court granted the defendants’ motion to bifurcate the motion to dismiss into two stages: a threshold motion to dismiss for lack of personal jurisdiction, lack of subject matter jurisdiction, and insufficient process and service of process, due on July 31, 2017; and, if the matter is not dismissed following that threshold motion, a subsequent merits motion to dismiss regarding whether the allegations in the amended complaint state a claim under the securities laws. The Company believes that the amended complaint is without merit and plans to defend the consolidated lawsuits vigorously. The Company has not accrued

- 8 -

any amounts in respect of these lawsuits, as a liability is not probable and the amount of any potential liability cannot be reasonably estimated.

NOTE 5: SHARE CAPITAL

For the six months ended June 30, 2017, warrants to purchase 1,417,097 ordinary shares with an exercise price of $3.59 per share were cashlessly exercised, resulting in the issuance of 801,845 ordinary shares. Also, warrants to purchase 6,498 ordinary shares with an exercise price of $3.59 per share were exercised for cash. For the six months ended June 30, 2017, options to purchase 639,902 ordinary shares were exercised for cash, resulting in the issuance of 639,902 ordinary shares.

NOTE 6: EQUITY INCENTIVE PLANS

In September 2015, the Company adopted the 2015 Omnibus Incentive Plan (the “2015 Plan”). Under the 2015 Plan, the Company can issue various types of equity compensation awards such as share options, restricted shares, performance shares, restricted stock units (“RSUs”), performance units, long-term cash award and other share-based awards.

Options granted under the 2015 Plan generally have a four-year vesting period and expire ten years after the date of grant. Options granted under the 2015 Plan that are cancelled or forfeited before expiration become available for future grants. RSUs granted under the 2015 Plan vest in equal installments over a three-year period. As of June 30, 2017, 9,824,964 ordinary shares were available for grant under the 2015 Plan.

A summary of the status of the Company’s option plans as of June 30, 2017 and changes during the period then ended is presented below:

	Six months ended June 30, 2017
	Unaudited
	Number of options			Weighted average exercise price
Outstanding at beginning of year		11,377,354		$	9.76
Granted		4,757,238			9.25
Exercised		(639,902	)		2.13
Forfeited and cancelled		(205,370	)		12.65
Outstanding as of June 30, 2017		15,289,320			9.88

Exercisable options		6,722,358			7.49

Vested and expected to vest		15,289,320		$	9.88

A summary of the status of the Company’s RSUs as of June 30, 2017 and changes during the period then ended is presented below:

	Six months ended June 30, 2017
	Unaudited
	Number of RSUs		Weighted average grant date fair value price
Unvested at beginning of year		-	$	-
Granted		1,661,619		9.64
Vested		-		-
Forfeited and cancelled		-		-
Unvested as of June 30, 2017		1,661,619	$	9.64

- 9 -

Company began its offerings under the ESPP on August 1, 2016. As of June 30, 2017, 2,328,171 ordinary shares were available to be purchased by eligible employees under the ESPP and 209,355 shares had been issued under the ESPP.

The fair value of equity-based awards was estimated using the Black-Scholes option-pricing model for all grants with the following underlying assumptions:

	Six months ended June 30,			Year ended December 31,
	2017	2016		2016
	Unaudited			Audited
Stock Option Plans
Expected term (years)	5.5-6.25	6.25		6.25
Expected volatility	56.74%-59.15%	59.80%-61.65%		58.40%-61.70%
Risk-free interest rate	1.99%-2.23%	1.23%-1.88%		1.23%-1.88%
Dividend yield	0.00%	0.00%		0.00%
ESPP
Expected term (years)	0.50		-	0.42
Expected volatility	82.00%		-	70.45%
Risk-free interest rate	0.62%		-	0.40%
Dividend yield	0.00%		-	0.00%

The total non-cash share-based compensation expense related to all of the Company’s equity-based awards recognized for the three and six months ended June 30, 2017 and 2016 and the year ended December 31, 2016 was:

	Three months ended June 30,				Six months ended June 30,				Year ended December 31,
	2017		2016		2017		2016		2016
	Unaudited				Unaudited				Audited
Cost of revenues	$	131	$	170	$	274	$	311	$	623
Research, development and clinical trials		811		839		1,673		1,602		3,155
Sales and marketing		1,735		1,349		2,390		2,639		5,111
General and administrative		4,893		3,279		7,794		6,541		12,552
Total share-based compensation expense	$	7,570	$	5,637	$	12,131	$	11,093	$	21,441

NOTE 7: SUPPLEMENTAL INFORMATION

The Company operates in a single reportable segment.

The following table presents long-lived assets by location:

	June 30,		December 31,
	2017		2016
	Unaudited		Audited
United States	$	12,096	$	11,981
Switzerland		4,358		4,346
Israel		1,777		1,915
Others	451			378
Total	$	18,682	$	18,620

- 10 -

The Company’s revenues by geographic region, based on the customer’s location, are summarized as follows:

	Three months ended June 30,				Six months ended June 30,				Year ended December 31,
	2017		2016		2017		2016		2016
	Unaudited				Unaudited				Audited
United States	$	31,367	$	16,122	$	60,526	$	28,135	$	72,771
EMEA (*)		6,891		1,797		12,559		2,775		10,028
Japan		118		-		171		62		89
Total	$	38,376	$	17,919	$	73,256	$	30,972	$	82,888

(*) including Germany	$	6,817	$	1,766		12,216		2,659	$	9,799

- 11 -

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to provide information to assist you in better understanding and evaluating our financial condition and results of operations. We encourage you to read this MD&A in conjunction with our consolidated financial statements and the notes thereto for the period ended June 30, 2017 included in Part I, Item 1 of this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that involve risks and uncertainties. As a result of many factors, such as those set forth under Part I, Item 1A, “Risk Factors”, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “2016 10-K”), our actual results may differ materially from those anticipated in these forward-looking statements. References to the words “we,” “our,” “us,” and the “Company” in this report refer to NovoCure Limited, including its consolidated subsidiaries.

Overview

We are a commercial stage oncology company developing a profoundly different cancer treatment centered on a proprietary therapy called Tumor Treating Fields (“TTFields”), the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Our key priorities are to accelerate commercial adoption of Optune, our first commercial TTFields delivery system, for the treatment of glioblastoma (“GBM”) and to advance programs testing the efficacy and safety of TTFields in multiple solid tumor indications through our clinical pipeline.

We were founded in 2000 and operated as a development stage company through December 31, 2011. We initially received U.S. Food and Drug Administration (“FDA”) approval for Optune in 2011 for use as a monotherapy treatment for adult patients with GBM following confirmed recurrence after chemotherapy. In October 2015, we received FDA approval to market Optune for the treatment of adult patients with newly diagnosed GBM in combination with temozolomide, a chemotherapy drug. We have also received approval to market Optune in Germany, Switzerland, Israel, Japan and certain other countries. To date, we have focused on commercializing Optune in the United States, Germany, Switzerland, Israel and Japan, which we refer to collectively as our currently active markets.

In April 2017, we announced final analyses of the full 695 patient dataset with a median follow-up of 40 months from our phase 3 pivotal trial of Optune in combination with temozolomide for patients with newly diagnosed GBM. For patients treated with Optune in combination with temozolomide versus patients treated with temozolomide alone, the two-year survival rate increased from 30 percent to 43 percent and the five-year survival rate increased from five percent to 13 percent. These data further support our belief that Optune plus temozolomide is an essential combination treatment for patients with newly diagnosed GBM.

We continue to work with payers to expand access to Optune for patients with newly diagnosed and recurrent GBM. As of June 30, 2017, more than 204 million Americans have available coverage for the use of Optune for newly diagnosed and/or recurrent GBM. Additionally, we have signed contracts to establish Optune as an in-network benefit for more than 174 million American lives. The percentage of our U.S. active patient population who are beneficiaries of the Medicare fee-for-service program, which has denied coverage for our claims to date, continues to range from 20 to 25 percent.

In March 2017, we received Japanese Ministry of Health, Labour and Welfare (“MHLW”) approval for the second generation Optune system. In March 2017, we filed an application to request a defined reimbursement rate for Optune based on the December 2016 regulatory approval of Optune to treat newly diagnosed GBM. We are currently in active reimbursement discussions with the MHLW and anticipate receiving feedback in the third quarter 2017.

We have researched the biological effects of TTFields extensively. Because TTFields are delivered regionally, act only on dividing cells (a biological process known as mitosis) and are frequency-tuned to target cells of a specific size, we believe there is minimal damage to healthy cells. We believe our pre-clinical and clinical research demonstrates that TTFields’ mechanism of action affects fundamental aspects of cell division and may have broad applicability across a variety of solid tumors. We have demonstrated in pre-clinical studies that TTFields can offer additive or synergistic benefits in combination with radiation, chemotherapy and immunotherapy, which may lead to greater efficacy than radiation, chemotherapy and immunotherapy alone, without significantly increasing the side effects when used in combination with other cancer treatments.

- 12 -

We are currently planning or conducting clinical trials evaluating the use of TTFields in brain metastases, non-small-cell lung cancer (“NSCLC”), pancreatic cancer, ovarian cancer and mesothelioma. We anticipate expanding our clinical pipeline over time to study the safety and efficacy of TTFields for additional solid tumor indications. The table below presents the current status of our clinical pipeline.

In May 2017, we received humanitarian use device (HUD) designation for the use of TTFields for the treatment of pleural mesothelioma. The HUD designation is the first step in obtaining a Humanitarian Device Exemption (HDE) for the treatment of pleural mesothelioma with TTFields. An approved HDE would allow Novocure to market TTFields in combination with standard of care chemotherapy as a treatment for pleural mesothelioma in the United States.

We own all commercialization rights to TTFields in oncology. Our robust global patent and intellectual property portfolio consists of over 120 issued patents, with numerous additional patent applications pending worldwide. The patents have expected expiration dates between 2021 and 2035. We have also filed over 50 additional patent applications that, if issued, may protect aspects of our platform beyond 2035. We believe we will maintain exclusive rights to market TTFields for all solid tumor indications in our key markets through the life of our patents.

We were incorporated in the Bailiwick of Jersey in 2000. Our U.S. operations are located in Portsmouth, New Hampshire, Malvern, Pennsylvania, and New York City. Additionally, we have offices in Germany, Switzerland, Israel and Japan, and a research center in Israel. We completed our initial public offering of our ordinary shares in October 2015. Our ordinary shares are quoted on the NASDAQ Global Select Market under the symbol “NVCR.”

Financial Overview. We expect to continue to incur significant expenses and operating losses for at least the next several years. We expect our research, development and clinical trials expenses to increase in connection with our ongoing activities, and as additional indications enter late-stage clinical development. In addition, we expect to incur significant commercialization expenses for product sales, marketing, manufacturing and distribution. We may need additional funding to support the continuation of our operating activities. Until we can generate substantial revenues (which may not occur), we expect to finance our cash needs through our existing cash, cash equivalents, short-term investments, equity issuances or additional debt, and possibly also from collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements. We will need to generate significant revenues to achieve profitability, and we may never do so.

Critical accounting policies and estimates

In accordance with U.S. GAAP, in preparing our financial statements, we must make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of net revenues and expenses during the reporting period. We develop and periodically change these estimates and assumptions based on historical experience and on various other factors that we believe are reasonable under the circumstances. Actual results may differ from these estimates.

The critical accounting policies requiring estimates, assumptions and judgments that we believe have the most significant impact on our consolidated financial statements can be found in our 2016 10-K. There have been no material changes to our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our 2016 10-K.

Results of Operations

We account for revenue when all revenue recognition criteria have been met or when cash is collected. Revenue recognized in a given period may include a mixture of accrued revenue, cash collections from amounts billed in prior periods and cash collections from amounts billed in the current period. We report certain operating statistics to provide additional insight into the commercial performance of Optune in our currently active markets.

- 13 -

Prescriptions are a leading indicator of Optune demand. The conversion of prescriptions to new patients is driven by the prescription fill rate and the time to fill. In the twelve months ended June 30, 2017, our prescription fill rate was between 70-75%. The number of active patients on Optune is our principal revenue driver. Growth in the number of active patients is a factor of both new patient starts and treatment duration. Median treatment duration differs based upon the clinical diagnosis of the patient. For the three months ended June 30, 2017, more than 55% of prescriptions received were for patients with newly diagnosed GBM.

The following table includes certain commercial operating statistics for and as of the end of the periods presented.

	Three months ended June 30,				Six months ended June 30,
Operating statistics	2017		2016		2017		2016
Prescriptions received in period (1)
United States		803		547		1,488		1,231
EMEA (2) (*)		255		110		461		181
Japan (2)		1		-		4		-
		1,059		657		1,953		1,412

(*) including Germany		189		76		351		134

					June 30,
					2017		2016
Active patients at period end (3)
United States						1,083		736
EMEA (2) (*)						376		155
Japan (2)						1		-
						1,460		891

(*) including Germany						278		111

(1)	A “prescription received” is a commercial order for Optune that is received from a physician certified to treat patients with Optune for a patient not previously on Optune. Orders to renew or extend treatment are not included in this total.

(2)	As we enter each new market, our commercial activities focus initially on establishing the required in-market infrastructure, certifying physicians to prescribe Optune and obtaining a defined reimbursement pathway. Once established, our commercial efforts turn to increasing adoption.

(3)	An “active patient” is a patient who is on Optune under a commercial prescription order as of the measurement date, including patients who may be on a temporary break from treatment and who plan to resume treatment in less than 60 days.

Net revenues. Substantially all of our revenues are derived from patients using our TTFields delivery system, marketed as Optune in our currently active markets. We charge patients or their third-party healthcare payers directly on a monthly basis and bear the financial risk of securing payment in the United States and Europe.

The following is a summary of gross billings and revenues recorded on an accrual basis and a cash basis by quarters (unaudited):

	2017					2016
U.S. dollars in millions		Q2		Q1		Q4		Q3		Q2		Q1
Gross billings		$	87.2	$	73.2	$	63.8	$	57.5	$	54.0	$	45.5

Accrual basis revenue		$	19.1	$	14.7	$	8.5	$	0.0	$	0.0	$	0.0
Cash basis revenue for therapy provided in the period			5.7		5.9		6.3		8.9		7.6		5.6
Cash basis revenue for therapy provided in previous periods			13.6		14.3		15.5		12.7		10.3		7.4
Net revenues		$	38.4	$	34.9	$	30.2	$	21.7	$	17.9	$	13.1

- 14 -

We began recognizing a portion of our net revenues on an accrual basis in the fourth quarter 2016. All of the net revenues recognized on an accrual basis represent charges to certain U.S.-based third-party payers. In the table above, gross billings reflect the total charges for active patients on Optune without any deductions or adjustments for payer discounts, patient financial assistance, charitable care or other similar items. The subsequent table line items detail the three sources of net revenue in the applicable reporting period. We believe there will be an extended period of time when our revenue is a mix of both cash-based and accrual-based revenue.

Cost of revenues. Our cost of revenues is comprised primarily of (i) cost of the disposable transducer arrays purchased from third-party manufacturers, (ii) depreciation expense for field equipment, including the electric field generator used by patients and (iii) personnel, warranty and overhead costs such as facilities, freight and depreciation of property, plant and equipment associated with managing our inventory, warehousing and order fulfillment functions.

Operating Expenses. Our operating expenses consist of research, development and clinical trials, sales and marketing and general and administrative expenses. Personnel costs are a significant component for each category of operating expenses and consist of wages, benefits and bonuses. Personnel costs also include share-based compensation.

Financial expenses, net. Financial expenses, net primarily consists of interest expense and related debt issuance costs under our Term Loan Credit Facility, interest income from cash balances and short-term investments and gains (losses) from foreign currency transactions.

We view our operations and manage our business in one operating segment. For the three and six months ended June 30, 2017, our net revenues were $38.4 million and $73.3 million, respectively, and our net loss was $21.2 million and $39.2 million, respectively. Our net loss for the three and six months ended June 30, 2017 includes $7.6 million and $12.1 million, respectively, in non-cash share-based compensation expense. As of June 30, 2017, we had an accumulated deficit of $559.8 million.

Three months ended June 30, 2017 compared to three months ended June 30, 2016

(All dollar figures in tables are in thousands unless otherwise indicated)

	Three months ended June 30,
	2017		2016		Change		% Change
Net revenues	$	38,376	$	17,919	$	20,457		114	%

Net revenues. Net revenues increased $20.5 million, or 114%, to $38.4 million for the three months ended June 30, 2017 from $17.9 million for the three months ended June 30, 2016. This was primarily due to an increase of $15.2 million in commercial sales of Optune in the United States and an increase of $5.2 million in commercial sales of Optune in our other currently active markets.

For the three months ended June 30, 2017, gross billings totaled $87.2 million. 24% of our gross billings qualified for accrual-based net revenue recognition. Of those qualifying gross billings, net revenues recorded on an accrual basis during the three months ended June 30, 2017, were $19.1 million. Net revenues recorded on a cash basis during the three months ended June 30, 2017 were $19.3 million.

Cost of revenues. Our cost of revenues (excluding the impairment of field equipment described below) increased by $3.4 million, or 34%, to $13.2 million for the three months ended June 30, 2017 from $9.8 million for the three months ended June 30, 2016. The increase was primarily due to increases of $2.7 million in transducer arrays shipped to commercial patients, $0.4 million for field equipment depreciation, and $0.3 million of personnel costs, including $0.1 million of non-cash share-based compensation. Each of these increases were primarily driven by the increase in active patients period-to-period.

We received FDA approval on our PMA supplement application to market second generation Optune in the United States in July 2016. In the second quarter 2016, we recorded an impairment loss with respect to the write-off of first generation Optune field equipment (finished goods and production stage) in the amount of $6.4 million that was not recoverable and was presented in cost of revenues. We do not expect the conversion to result in an additional material impairment charge in the future.

- 15 -

Operating Expenses.

	Three months ended June 30,
	2017		2016		Change			% Change
Research, development and clinical trials	$	9,371	$	11,318	$	(1,947	)		(17	%)
Sales and marketing		16,360		14,598		1,762			12	%
General and administrative		15,023		13,031		1,992			15	%
Total operating expenses	$	40,754	$	38,947	$	1,807			5	%

Non-cash expenses:
Share-based compensation expense	$	7,439	$	5,467	$	1,972			36	%
Other non-cash expenses		573		709		(136	)		(19	%)
Total non-cash expenses	$	8,012	$	6,176	$	1,836			30	%

Total operating expenses, net of non-cash expenses *	$	32,742	$	32,771	$	(29	)		(0	%)

*	This non-GAAP metric has been included because management believes that it provides for a more accurate year to year comparison of our operating expenses without the impact of non-cash items.

Research, development and clinical trials expenses. Research, development and clinical trials expenses decreased $1.9 million, or 17%, to $9.4 million for the three months ended June 30, 2017 from $11.3 million for the three months ended June 30, 2016. The change is primarily due to a decrease in clinical trial expenses resulting from the conclusion of our EF-14 phase 3 pivotal trial in newly diagnosed GBM. These expenses include $0.8 million of non-cash share-based compensation.

Sales and marketing expenses. Sales and marketing expenses increased $1.8 million, or 12%, to $16.4 million for the three months ended June 30, 2017 from $14.6 million for the three months ended June 30, 2016. The change was primarily due to an increase of $2.5 million in personnel costs, including $0.4 million in non-cash share-based compensation, and an increase of $0.4 million in commercial shipping charges, reflecting our expanding commercial operations in the United States and Germany, partially offset by a decrease of $1.2 million in marketing expenses primarily related to advertising and professional services for the launch of second generation Optune and the communication of our inclusion in the updated National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Central Nervous System Cancer (“NCCN Guidelines”).

General and administrative expenses. General and administrative expenses increased $2.0 million, or 15%, to $15.0 million for the three months ended June 30, 2017 from $13.0 million for the three months ended June 30, 2016. The change was primarily due to an increase of $2.6 million in personnel costs, including $1.6 million in share based compensation, partially offset by a decrease of $0.6 million in professional services and other expenses. Personnel costs include $4.9 million of non-cash share-based compensation expense, including equity awards granted to our executive chairman and expenses related to our employee share purchase plan (“ESPP”).

Financial expenses, net. Financial expenses, net increased by $1.6 million, or 293%, to $2.2 million for the three months ended June 30, 2017 from $0.6 million for the three months ended June 30, 2016. The change is primarily due to an increase in interest expense, including amortization expense of the discount and deferred issuance costs, related to our July 2016 withdrawal of the remaining $75 million in available funds under the term loan credit facility that we, as borrower, entered into with BioPharma Secured Investments III Holdings Cayman LP, as lender, in January 2015, amended as of December 2016 and February 2017 (collectively, the “Term Loan Credit Facility”).

	Three months ended June 30,
	2017		2016		Change		% Change
Income tax expenses	$	3,461	$	2,820	$	641		23	%

Income taxes. Income taxes increased $0.6 million, or 23%, to $3.5 million for the three months ended June 30, 2017 from $2.8 million for the three months ended June 30, 2016. The increase was primarily a result of a change in the mix of applicable statutory tax rates in certain non-US jurisdictions.

- 16 -

Six months ended June 30, 2017 compared to six months ended June 30, 2016

(All dollar figures in tables are in thousands unless otherwise indicated)

	Six months ended June 30,
	2017		2016		Change		% Change
Net revenues	$	73,256	$	30,972	$	42,284		137	%

Net revenues. Net revenues increased by $42.3 million, or 137%, to $73.3 million for the six months ended June 30, 2017 from $31.0 million for the six months ended June 30, 2016. The increase was primarily due to an increase of $32.4 million in commercial sales of Optune in the United States, driven by an increase in Optune adoption as well as due to an increase of $9.9 million in commercial sales of Optune in our other currently active markets, also driven by an increase in Optune adoption.

For the six months ended June 30, 2017, gross billings totaled $160.4 million. 23% of our gross billings qualified for accrual-based net revenue recognition. Of those qualifying gross billings, net revenues recorded on an accrual basis during the six months ended June 30, 2017, were $33.8 million. Net revenues recorded on a cash basis during the six months ended June 30, 2017 were $39.4 million.

Cost of revenues. Our cost of revenues (excluding the impairment of field equipment described below) increased by $7.0 million, or 40%, to $24.8 million for the six months ended June 30, 2017 from $17.8 million for the six months ended June 30, 2016. The increase was primarily due to increases of $5.9 million in transducer arrays shipped to commercial patients, $0.7 million for field equipment, and $0.4 million of personnel costs, including $0.3 million of non-cash share-based compensation. Each of these increases were primarily driven by the increase in active patients period-to-period.

We received FDA approval on our PMA supplement application to market our second generation Optune System in the United States in July 2016. In the second quarter 2016, we recorded an impairment loss with respect to the write-off of first generation Optune System field equipment (finished goods and production stage) in the amount of $6.4 million that was not recoverable and was presented in cost of revenues. We do not expect the conversion to result in an additional material impairment charge in the future.

Operating Expenses.

	Six months ended June 30,
	2017		2016		Change			% Change
Research, development and clinical trials	$	18,782	$	22,763	$	(3,981	)		(17	%)
Sales and marketing		31,116		27,906		3,210			12	%
General and administrative		27,445		25,287		2,158			9	%
Total operating expenses	$	77,343	$	75,956	$	1,387			2	%

Non-cash expenses:
Share-based compensation expense	$	11,857	$	10,782	$	1,075			10	%
Other non-cash expenses		1,149		1,315		(166	)		(13	%)
Total non-cash expenses	$	13,006	$	12,097	$	909			8	%

Total operating expenses, net of non-cash expenses	$	64,337	$	63,859	$	478			1	%

*	This non-GAAP metric has been included because management believes that it provides for a more accurate year to year comparison of our operating expenses without the impact of non-cash items.

Research, development and clinical trials expenses. Research, development and clinical trials expenses decreased $4.0 million, or 17%, to $18.8 million for the six months ended June 30, 2017 from $22.8 million for the six months ended June 30, 2016. The change is primarily due to a decrease of in clinical trial expenses resulting from the conclusion of our EF-14 phase 3 pivotal trial in newly diagnosed GBM. These expenses include $1.7 million of non-cash share-based compensation.

Sales and marketing expenses. Sales and marketing expenses increased by $3.2 million, or 12%, to $31.1 million for the six months ended June 30, 2017 from $27.9 million for the six months ended June 30, 2016. The change was primarily due to an increase of $4.3 million in personnel costs, including $2.4 million of non-cash share-based compensation and an increase of $0.9 million in commercial shipping charges, reflecting our expanding commercial operations in the United States and Germany, partially offset by a decrease of $2.0 million in marketing expenses primarily related to advertising and professional services for the launch of second generation Optune and the communication of our inclusion in NCCN Guidelines.

- 17 -

General and administrative expenses. General and administrative expenses increased $2.2 million, or 9%, to $27.4 million for the six months ended June 30, 2017 from $25.3 million for the six months ended June 30, 2016. The change was primarily due to an increase of $3.1 million in personnel costs, including $1.3 million in share based compensation, partially offset by a decrease of $0.9 million in professional services and other expenses. Personnel costs include $7.8 million of non-cash share-based compensation expense, including equity awards granted to our executive chairman and expenses related to our ESPP.

Financial expenses, net. Financial expenses, net increased by $3.5 million, or 319%, to $4.6 million for the six months ended June 30, 2017 from $1.1 million for the six months ended June 30, 2016. The change is primarily due to an increase in interest expense, including amortization expense of the discount and deferred issuance costs, related to our July 2016 withdrawal of the remaining $75 million in available funds under the term loan credit facility that we, as borrower, entered into with BioPharma Secured Investments III Holdings Cayman LP, as lender, in January 2015, amended as of December 2016 and February 2017 (collectively, the “Term Loan Credit Facility”).

	Six months ended June 30,
	2017		2016		Change			% Change
Income tax expenses	$	5,687	$	5,770	$	(83	)		(1	%)

Income taxes. Income taxes decreased by $0.1 million to $5.7 million for the six months ended June 30, 2017 from $5.8 million for the six months ended June 30, 2016. The decrease was primarily a result of a change in the mix of applicable statutory tax rates in certain non-US jurisdictions.

Liquidity and Capital Resources

Sources of Liquidity

Since inception, we have financed our operations primarily through the issuance and sale of equity and the proceeds from long-term loans. As of June 30, 2017, we had received a total of $714.1 million from these activities. As of June 30, 2017, we had an accumulated deficit of $559.8 million since inception.

Our net losses were $39.2 million for the six months ended June 30, 2017 and $131.8 million for the year ended December 31, 2016. Our net losses primarily resulted from costs incurred in connection with our pre-clinical and clinical trial programs, costs incurred in our commercial launch efforts, and general and administrative costs necessary to operate as a multi-national oncology business.

As of June 30, 2017, we had $80.2 million of cash and cash equivalents and $104.2 million of short-term investments. We believe our cash and cash equivalents and short term investments as of June 30, 2017, are sufficient for our operations for at least the next twelve months based on our existing business plan and our ability to control the timing of significant expense commitments. We expect that our research, development and clinical trials expenses, sales and marketing expenses and general and administrative expenses will continue to increase over the next several years. As a result, we may need to raise additional capital in the future to fund our operations.

	Six months ended June 30,
	2017			2016
Net cash used in operating activities	$	(32,783	)	$	(60,371	)
Net cash provided by investing activities		11,057			20,820
Net cash provided by financing activities		2,126			943
Net decrease in cash and cash equivalents		(19,600	)		(38,608	)
Effect of exchange rates on cash and cash equivalents		10			56
Changes in short-term investments		(15,994	)		(30,022	)
Net decrease in cash, cash equivalents and short-term investments	$	(35,584	)	$	(68,574	)

Operating activities

Net cash used in operating activities primarily represents our net loss for the periods presented. Adjustments to net loss for non-cash items include depreciation and amortization, share-based compensation, accrued interest and impairments. Operating cash flows are also impacted by changes in operating assets and liabilities, principally trade receivables, inventories, prepaid expenses, trade payables and accrued expenses.

- 18 -

Net cash used in operating activities was $32.8 million for the six months ended June 30, 2017, as compared to $60.4 million for the six months ended June 30, 2016, reflecting a net loss of $39.2 million and a change of $9.5 million in our net operating assets and liabilities, partially offset by non-cash charges of $15.9 million.

The change in our net operating assets and liabilities was primarily the result of an increase in other payables of $3.5 million, an increase in other long-term liabilities of $0.9 million, and a decrease in inventories of $0.4 million offset by an increase in trade receivables of $7.6 million, a decrease in trade payables of $5.2 million, and an increase in other receivables of $1.5 million. Non-cash charges included $12.1 million of share-based compensation and $3.5 million of depreciation.

Investing activities

Our investing activities consist primarily of capital expenditures to purchase property and equipment and field equipment, as well as investments in and redemptions of our short-term investments.

Net cash provided by investing activities was $11.1 million for the six months ended June 30, 2017, compared to $20.8 million for the six months ended June 30, 2016, reflecting a decrease attributable to our receipt of $120.0 million from the maturity of short-term investments, partially offset by the purchase of $104.0 million of new short-term investments, purchases of $2.3 million of field equipment, purchases of $1.4 million of property and equipment, and a $1.3 million increase in restricted cash.

Financing activities

To date, our primary financing activities have been the sale of equity and the proceeds from long-term loans.

Net cash provided by financing activities was $2.1 million for the six months ended June 30, 2017, as compared to $0.9 million for the six months ended June 30, 2016, reflecting proceeds received from the exercise of warrants and options and our ESPP.

Our material outstanding indebtedness consists of our Term Loan Credit Facility. As of June 30, 2017, the aggregate principal balance of amounts outstanding under the Term Loan Credit Facility was $100.0 million. We may prepay the term loans, in whole, at any time, and must prepay in the event of a change of control, in each case, subject to a pay-down fee, prepayment premium and/or make-whole payment. Interest on the outstanding loan is 10% annually, payable quarterly in arrears. The pay-down fee on all principal payments to be paid on the date such payments are made is 0.75% and the pre-payment fee if we prepay outstanding loan amounts prior to the first, second or third year from the initial funding date is 3.0%, 2.0% or 1.0%, respectively.

All obligations under the Term Loan Credit Facility are guaranteed by certain of our current and future domestic direct and indirect subsidiaries. In addition, the obligations under the Term Loan Credit Facility are secured by a first-priority security interest in substantially all of the property and assets of, as well as the equity interests owned by, us and the other guarantors. On March 28, 2017, the Term Loan Credit Facility was amended as of February 21, 2017 to increase to $1.5 million the limit in the Company’s pledges and deposits security liability for reimbursement or indemnification obligations in respect of letters of credit or bank guarantees for the benefit of the Company’s landlords.

The Term Loan Credit Facility has a minimum liquidity covenant, which is tested quarterly. In addition, we must meet certain pro forma net sales requirements. The Term Loan Credit Facility also contains other customary covenants.

Contractual Obligations and Commitments

There were no material changes in our commitments under contractual obligations during the three months ended June 30, 2017.

The total amount of unrecognized tax benefits for uncertain tax positions was $3.2 million and $2.4 million at June 30, 2017 and December 31, 2016, respectively. Payment of these obligations would result from settlements with taxing authorities. We do not expect a significant tax payment related to these obligations within the next year.

Off-Balance Sheet Arrangements

We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements as defined under SEC rules.

- 19 -

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2017. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of June 30, 2017, our Chief Executive Officer and Chief Financial Officer have concluded that, as of June 30, 2017, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the quarter ended June 30, 2017, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

- 20 -

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

In June 2017, certain investors in our 2007 Series E preferred shares offering cashlessly exercised warrants to purchase 24,643 ordinary shares with an exercise price of $3.59 per share, resulting in the issuance of 22,116 ordinary shares. Additionally, in June 2017, an investor in our 2007 Series E preferred shares offering exercised warrants to purchase 6,159 ordinary shares with an exercise price of $3.59 per share. We believe that these issuances were exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on Regulation S under the Securities Act, under Section 4(a)(2) of the Securities Act regarding transactions not involving a public offering and under Rule 701 promulgated under the Securities Act.

- 21 -

Item 6. Exhibits

EXHIBIT INDEX

Exhibit		Incorporated by Reference			Filed
Number	Exhibit Description	Form	Date	Number	Herewith

10.1	Second Amendment to Loan and Security Agreement, dated as of February 21, 2017, by and between NovoCure Limited and BioPharma Secured Investments III Holdings Cayman LP	8-K	3/31/17	10.1
10.2	Form of Indemnification Agreement	8-K	3/22/16	10.1
10.3	Form of Incentive Stock Option Agreement pursuant to the 2015 Omnibus Incentive Plan	8-K	5/12/17	10.1
10.4	Form of Non-Qualified Stock Option Agreement pursuant to the 2015 Omnibus Incentive Plan	8-K	5/12/17	10.2
31.1	Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended				X
31.2	Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended				X
32.1*	Certification of Principal Executive Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350				X
32.2*	Certification of Principal Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350				X
101.INS	XBRL Instance Document				X
101.SCH	XBRL Taxonomy Extension Schema Document				X
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document				X
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document				X
101.LAB	XBRL Taxonomy Extension Label Linkbase Document				X
101.PRE	XBRL Extension Presentation Linkbase Document				X

The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of NovoCure Limited under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.

- 22 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		NovoCure Limited

Date: July 27, 2017		/s/ Wilco Groenhuysen
		Wilco Groenhuysen
		Chief Financial Officer
		(principal financial and accounting officer and duly authorized officer)

- 23 -

EXHIBIT INDEX

Exhibit		Incorporated by Reference			Filed
Number	Exhibit Description	Form	Date	Number	Herewith

10.1	Second Amendment to Loan and Security Agreement, dated as of February 21, 2017, by and between NovoCure Limited and BioPharma Secured Investments III Holdings Cayman LP	8-K	3/31/17	10.1
10.2	Form of Indemnification Agreement	8-K	3/22/16	10.1
10.3	Form of Incentive Stock Option Agreement pursuant to the 2015 Omnibus Incentive Plan	8-K	5/12/17	10.1
10.4	Form of Non-Qualified Stock Option Agreement pursuant to the 2015 Omnibus Incentive Plan	8-K	5/12/17	10.2
31.1	Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended				X
31.2	Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended				X
32.1*	Certification of Principal Executive Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350				X
32.2*	Certification of Principal Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350				X
101.INS	XBRL Instance Document				X
101.SCH	XBRL Taxonomy Extension Schema Document				X
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document				X
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document				X
101.LAB	XBRL Taxonomy Extension Label Linkbase Document				X
101.PRE	XBRL Extension Presentation Linkbase Document				X

- 24 -

EX-31.1 2 nvcr-ex311_8.htm EXHIBIT 31.1 nvcr-ex311_8.htm

Exhibit 31.1

CERTIFICATIONS

I, Asaf Danziger, certify that:

I have reviewed this Quarterly Report on Form 10-Q of NovoCure Limited;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: July 27, 2017

/s/ Asaf Danziger

Asaf Danziger

Chief Executive Officer and Director

(Principal Executive Officer)

EX-31.2 3 nvcr-ex312_7.htm EXHIBIT 31.2 nvcr-ex312_7.htm

Exhibit 31.2

CERTIFICATIONS

I, Wilco Groenhuysen, certify that:

I have reviewed this Quarterly Report on Form 10-Q of NovoCure Limited;

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: July 27, 2017

/s/ Wilco Groenhuysen

Wilco Groenhuysen

Chief Financial Officer

(Principal Accounting and Financial Officer)

EX-32.1 4 nvcr-ex321_253.htm EX-32.1 DANZIGER nvcr-ex321_253.htm

Exhibit 32.1

NOVOCURE LIMITED

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NovoCure Limited (the "Company") on Form 10-Q for the quarter ended June 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Asaf Danziger, Chief Executive Officer (Principal Executive Officer) of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Asaf Danziger

Asaf Danziger

Chief Executive Officer

(Principal Executive Officer)

Date: July 27, 2017

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff on request.

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of NovoCure Limited under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.

EX-32.2 5 nvcr-ex322_254.htm EX-32.2 GROENHUYSEN nvcr-ex322_254.htm

Exhibit 32.2

NOVOCURE LIMITED

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NovoCure Limited (the "Company") on Form 10-Q for the quarter ended June 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Wilco Groenhuysen, Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Wilco Groenhuysen

Wilco Groenhuysen

Chief Financial Officer

(Principal Financial and Accounting Officer)

Date: July 27, 2017

GRAPHIC 6 g201707270721156573829.jpg GRAPHIC begin 644 g201707270721156573829.jpg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ǡ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�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end EX-101.INS 7 nvcr-20170630.xml XBRL INSTANCE DOCUMENT shares iso4217:USD iso4217:USD shares pure 0001645113 2017-01-01 2017-06-30 0001645113 2017-07-20 0001645113 2017-06-30 0001645113 2016-12-31 0001645113 2016-01-01 2016-12-31 0001645113 2017-04-01 2017-06-30 0001645113 2016-04-01 2016-06-30 0001645113 2016-01-01 2016-06-30 0001645113 us-gaap:CommonStockMember 2015-12-31 0001645113 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001645113 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0001645113 us-gaap:RetainedEarningsMember 2015-12-31 0001645113 2015-12-31 0001645113 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0001645113 us-gaap:CommonStockMember 2016-01-01 2016-12-31 0001645113 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-12-31 0001645113 us-gaap:RetainedEarningsMember 2016-01-01 2016-12-31 0001645113 us-gaap:CommonStockMember 2016-12-31 0001645113 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001645113 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001645113 us-gaap:RetainedEarningsMember 2016-12-31 0001645113 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-06-30 0001645113 us-gaap:CommonStockMember 2017-01-01 2017-06-30 0001645113 us-gaap:RetainedEarningsMember 2017-01-01 2017-06-30 0001645113 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-06-30 0001645113 us-gaap:CommonStockMember 2017-06-30 0001645113 us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0001645113 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-06-30 0001645113 us-gaap:RetainedEarningsMember 2017-06-30 0001645113 2017-03-31 0001645113 2016-03-31 0001645113 2016-06-30 0001645113 us-gaap:AccountingStandardsUpdate201609Member 2016-12-31 0001645113 us-gaap:MaximumMember 2017-01-01 2017-06-30 0001645113 us-gaap:VehiclesMember 2017-01-01 2017-06-30 0001645113 us-gaap:VehiclesMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0001645113 us-gaap:WarrantMember us-gaap:WarrantsNotSettleableInCashMember 2017-01-01 2017-06-30 0001645113 us-gaap:WarrantMember 2017-01-01 2017-06-30 0001645113 nvcr:TwoThousandFifteenPlanMember us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001645113 nvcr:TwoThousandFifteenPlanMember us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-06-30 0001645113 nvcr:TwoThousandFifteenPlanMember 2017-06-30 0001645113 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-06-30 0001645113 us-gaap:RestrictedStockUnitsRSUMember 2017-06-30 0001645113 us-gaap:EmployeeStockMember 2017-06-30 0001645113 us-gaap:EmployeeStockMember 2017-01-01 2017-06-30 0001645113 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-06-30 0001645113 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-12-31 0001645113 us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2017-01-01 2017-06-30 0001645113 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0001645113 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001645113 us-gaap:EmployeeStockMember 2016-01-01 2016-12-31 0001645113 nvcr:CostOfRevenueMember 2017-04-01 2017-06-30 0001645113 nvcr:CostOfRevenueMember 2016-04-01 2016-06-30 0001645113 nvcr:CostOfRevenueMember 2017-01-01 2017-06-30 0001645113 nvcr:CostOfRevenueMember 2016-01-01 2016-06-30 0001645113 nvcr:CostOfRevenueMember 2016-01-01 2016-12-31 0001645113 us-gaap:ResearchAndDevelopmentExpenseMember 2017-04-01 2017-06-30 0001645113 us-gaap:ResearchAndDevelopmentExpenseMember 2016-04-01 2016-06-30 0001645113 us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-06-30 0001645113 us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-01 2016-06-30 0001645113 us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-01 2016-12-31 0001645113 nvcr:SalesAndMarketingMember 2017-04-01 2017-06-30 0001645113 nvcr:SalesAndMarketingMember 2016-04-01 2016-06-30 0001645113 nvcr:SalesAndMarketingMember 2017-01-01 2017-06-30 0001645113 nvcr:SalesAndMarketingMember 2016-01-01 2016-06-30 0001645113 nvcr:SalesAndMarketingMember 2016-01-01 2016-12-31 0001645113 us-gaap:GeneralAndAdministrativeExpenseMember 2017-04-01 2017-06-30 0001645113 us-gaap:GeneralAndAdministrativeExpenseMember 2016-04-01 2016-06-30 0001645113 us-gaap:GeneralAndAdministrativeExpenseMember 2017-01-01 2017-06-30 0001645113 us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-01 2016-06-30 0001645113 us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-01 2016-12-31 0001645113 country:US 2017-06-30 0001645113 country:US 2016-12-31 0001645113 country:CH 2017-06-30 0001645113 country:CH 2016-12-31 0001645113 country:IL 2017-06-30 0001645113 country:IL 2016-12-31 0001645113 nvcr:OthersCountriesMember 2017-06-30 0001645113 nvcr:OthersCountriesMember 2016-12-31 0001645113 country:US 2017-04-01 2017-06-30 0001645113 country:US 2016-04-01 2016-06-30 0001645113 country:US 2017-01-01 2017-06-30 0001645113 country:US 2016-01-01 2016-06-30 0001645113 country:US 2016-01-01 2016-12-31 0001645113 us-gaap:EMEAMember 2017-04-01 2017-06-30 0001645113 us-gaap:EMEAMember 2016-04-01 2016-06-30 0001645113 us-gaap:EMEAMember 2017-01-01 2017-06-30 0001645113 us-gaap:EMEAMember 2016-01-01 2016-06-30 0001645113 us-gaap:EMEAMember 2016-01-01 2016-12-31 0001645113 country:JP 2017-04-01 2017-06-30 0001645113 country:JP 2017-01-01 2017-06-30 0001645113 country:JP 2016-01-01 2016-06-30 0001645113 country:JP 2016-01-01 2016-12-31 0001645113 country:DE 2017-04-01 2017-06-30 0001645113 country:DE 2016-04-01 2016-06-30 0001645113 country:DE 2017-01-01 2017-06-30 0001645113 country:DE 2016-01-01 2016-06-30 0001645113 country:DE 2016-01-01 2016-12-31 10-Q false 2017-06-30 2017 Q2 NVCR Novocure Ltd 0001645113 --12-31 Accelerated Filer 89002575

80190000

99780000

104186000

119854000

1537000

267000

13888000

6339000

11544000 10084000

25147000

25549000

236492000

261873000

9621000

9812000

9061000 8808000 102000 88000

1766000

1500000

20550000

20208000

257042000

282081000

13161000

18356000

22010000

18526000

35171000

36882000

96765000

96231000

2679000 2590000

4882000

4033000

104326000

102854000

139497000

139736000

679099000

664154000

-1739000

-1883000

-559815000

-519926000

117545000

142345000

257042000

282081000

Unlimited

88630205

87066446

88630205

87066446

38376000

17919000

73256000

30972000

82888000

13152000

9797000

24816000

17779000

39870000

6412000

25224000

1710000

48440000

6781000

36606000

9371000

11318000

18782000

22763000

41467000

16360000

14598000

31116000

27906000

59449000

15023000

13031000

27445000

25287000

51007000

40754000

38947000

77343000

75956000

151923000

-15530000

-37237000

-28903000

-69175000

-115317000

2183000

555000

4629000

1104000

6147000

-17713000

-37792000

-33532000

-70279000

-121464000

3461000

2820000

5687000

5770000

10381000

-21174000

-40612000

-39219000

-76049000

-131845000

-0.24

-0.48

-0.45

-0.90

-1.54

88218868

85274683

87835926

84843028

85558448

1000

56000

10000

56000

10000

-183000

-235000

-134000

235000

388000

-20990000

-40321000

-39075000

-76228000

-132223000

83778581

640406000

-1505000

-388081000

250820000

21441000

3195477 993000 993000

92388

616000

698000

-378000

-131845000

87066446

664154000

-1883000

-519926000

12131000

1446792 1363000 1363000

670000

-670000

116967

781000

144000

-39219000

88630205

679099000

-1739000

-559815000

-38000

-29000

1811000

1407000

3471000

2510000

5652000

59000

6425000

134000

6430000

6446000

-637000

7570000

5637000

12131000

11093000

22139000

698000

2064000

7550000

6339000

103000

-39000

209000

-56000

155000

-3354000 1672000 1461000 2208000 -243000

-803000

4769000

-403000

7621000

11955000

38000

111000

294000

278000

692000

-1638000

2321000

-5195000

4144000

1601000

4888000

2399000

3478000

756000

6647000

130000

32000

239000

270000

97000

321000

225000

871000

638000

957000

-5875000

-29394000

-32783000

-60371000

-107592000

376000

2338000

1407000

3340000

5674000

859000 4274000 2261000 6100000 11990000

1000

13000

1269000

12000

180000

60000000

120000000

150000000

270000000

59352000

104006000

119728000

239341000

-588000

-6625000

11057000

20820000

12815000

781000

616000

19000

17000

19000

17000

72887000

698000

19000

37000

35000

70000

1286000

904000

1363000

961000

993000

2067000

902000

2126000

943000

75124000

-1000

56000

10000

56000

10000

-4397000

-35061000

-19590000

-38552000

-19643000

84587000

115932000

119423000

80871000

1500000

1587000

4902000

3169000

9447000

2533000

1269000

5041000

1933000

6595000

<div> NOTE 3: INVENTORIES Inventories are stated at the lower of cost or market. The weighted average methodology is applied to determine cost. As of June 30, 2017 and December 31, 2016, the Company’s inventories were composed of:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Audited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,423</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,243</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work in progress</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,971</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,292</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished products</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,753</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,014</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,147</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,549</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> NOTE 4: COMMITMENTS AND CONTINGENT LIABILITIES The facilities of the Company are leased under various operating lease agreements for periods ending no later than 2024. The Company also leases motor vehicles under various operating leases, which expire on various dates, the latest of which is in 2020. As of June 30, 2017 and December 31, 2016, the Company pledged bank deposits of $1,051 and $807, respectively, to cover bank guarantees in respect of its leases of operating facilities and obtained guarantees by the bank for the fulfillment of the Company’s lease and other contractual commitments of $1,214 and $955, respectively. In January 2017, two putative class action lawsuits were filed against the Company, its directors and certain of its officers, as well as the underwriters in the Company’s October 2015 initial public offering.  The complaints, which purport to be brought on behalf of a class of persons and/or entities who purchased or otherwise acquired ordinary shares of the Company pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s initial public offering, allege material misstatements and/or omissions in the Company’s initial public offering materials in alleged violation of the federal securities laws and seek compensatory damages, among other remedies.  The two actions have been consolidated and the plaintiffs filed a consolidated amended complaint on May 31, 2017.  The court granted the defendants’ motion to bifurcate the motion to dismiss into two stages: a threshold motion to dismiss for lack of personal jurisdiction, lack of subject matter jurisdiction, and insufficient process and service of process, due on July 31, 2017; and, if the matter is not dismissed following that threshold motion, a subsequent merits motion to dismiss regarding whether the allegations in the amended complaint state a claim under the securities laws. The Company believes that the amended complaint is without merit and plans to defend the consolidated lawsuits vigorously. The Company has not accrued any amounts in respect of these lawsuits, as a liability is not probable and the amount of any potential liability cannot be reasonably estimated.</div>

<div> NOTE 6: EQUITY INCENTIVE PLANS In September 2015, the Company adopted the 2015 Omnibus Incentive Plan (the “2015 Plan”).  Under the 2015 Plan, the Company can issue various types of equity compensation awards such as share options, restricted shares, performance shares, restricted stock units (“RSUs”), performance units, long-term cash award and other share-based awards.   Options granted under the 2015 Plan generally have a four-year vesting period and expire ten years after the date of grant. Options granted under the 2015 Plan that are cancelled or forfeited before expiration become available for future grants. RSUs granted under the 2015 Plan vest in equal installments over a three-year period.  As of June 30, 2017, 9,824,964 ordinary shares were available for grant under the 2015 Plan.   A summary of the status of the Company’s option plans as of June 30, 2017 and changes during the period then ended is presented below:    <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30, 2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of options</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">exercise <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at beginning of year</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,377,354</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.76</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,757,238</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.25</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(639,902</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.13</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited and cancelled</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(205,370</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.65</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of June 30, 2017</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,289,320</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.88</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable options</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,722,358</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.49</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,289,320</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.88</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   A summary of the status of the Company’s RSUs as of June 30, 2017 and changes during the period then ended is presented below:    <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.76%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.58%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30, 2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.76%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.76%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of RSUs</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">grant date fair value <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested at beginning of year</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,661,619</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.64</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.76%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited and cancelled</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.76%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested as of June 30, 2017</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,661,619</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.64</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   In September 2015, the Company adopted an employee share purchase plan (“ESPP”) to encourage and enable eligible employees to acquire ownership of the Company’s ordinary shares purchased through accumulated payroll deductions on an after-tax basis. In the United States, the ESPP is intended to be an “employee stock purchase plan” within the meaning of Section 423 of the Internal Revenue Code and the provisions of the ESPP will be construed in a manner consistent with the requirements of such section. The Company began its offerings under the ESPP on August 1, 2016. As of June 30, 2017, 2,328,171 ordinary shares were available to be purchased by eligible employees under the ESPP and 209,355 shares had been issued under the ESPP. The fair value of equity-based awards was estimated using the Black-Scholes option-pricing model for all grants with the following underlying assumptions:    <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="4" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.8%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:16.02%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="4" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.8%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Audited</td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Option Plans</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5-6.25</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.25</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.25</td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.74%-59.15%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.80%-61.65%</td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58.40%-61.70%</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.99%-2.23%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23%-1.88%</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23%-1.88%</td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend yield</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00%</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ESPP</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.50</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.42</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82.00%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.45%</td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.62%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.40%</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend yield</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00%</td> </tr> </table></div>   The total non-cash share-based compensation expense related to all of the Company’s equity-based awards recognized for the three and six months ended June 30, 2017 and 2016 and the year ended December 31, 2016 was:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three months ended June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Audited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenues</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">274</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">311</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research, development and clinical trials</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">811</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">839</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,673</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,602</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,155</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,735</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,349</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,390</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,639</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,111</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,893</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,279</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,794</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,541</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,552</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total share-based compensation expense</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,570</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,637</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,131</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,093</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,441</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> Recently Adopted Accounting Pronouncements. In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendments in ASU 2016-09 affect all entities that issue share-based payment awards to their employees and involve multiple aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods.  The Company adopted ASU 2016-09 during the quarter ended March 31, 2017, at which time it changed its accounting policy to account for forfeitures as they occur. The change was applied on a modified retrospective basis with a cumulative effect adjustment to accumulated deficit of $670 as of January 1, 2017. In addition, excess tax benefits for share-based payments are now presented as an operating activity in the statements of cash flows rather than financing activity. The changes have been applied prospectively in accordance with the ASU and prior periods have not been adjusted. <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements. In May 2014, FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) (ASU 2014-09), which amends the existing accounting standards for revenue recognition. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delays the effective date of ASU 2014-09 by one year. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date.  The new revenue recognition standard will be effective in the first quarter of 2018, with the option to adopt it in the first quarter of 2017. The Company currently anticipates adopting the new standard effective January 1, 2018. The new standard also permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective method). The Company currently anticipates adopting the standard using the modified retrospective method. While the Company is still in the process of completing its assessment on the impact this guidance will have on its consolidated financial statements and related disclosures, the Company expects that the most significant impact relates to the accounting for revenue transactions whereby there is variable consideration. In April 2016, FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. ASU 2016-10 covers two specific topics: performance obligations and licensing. This amendment includes guidance on immaterial promised goods or services, shipping or handling activities, separately identifiable performance obligations, functional or symbolic intellectual property licenses, sales-based and usage-based royalties, license restrictions (time, use, geographical) and licensing renewals. In addition, in May 2016, FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, which is intended to not change the core principle of the guidance in Topic 606, but rather affect only the narrow aspects of Topic 606 by reducing the potential for diversity in practice at initial application and by reducing the cost and complexity of applying Topic 606 both at transition and on an ongoing basis. The Company is currently evaluating the impact of the adoption of both revenue standards on its consolidated financial statements. In February 2016, FASB issued ASU 2016-02-Leases (ASC 842), which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of their classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 supersedes the previous leases standard, ASC 840. The standard is effective on January 1, 2019, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements. In May 2017, FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting. ASU 2017-09 provides clarification on when modification accounting should be used for changes to the terms or conditions of a share-based payment award. This ASU does not change the accounting for modifications but clarifies that modification accounting guidance should only be applied if there is a change to the value, vesting conditions, or award classification and would not be required if the changes are considered non-substantive. The Company is evaluating the impact of ASU 2017-09.</div>

<div> Inventories are stated at the lower of cost or market. The weighted average methodology is applied to determine cost. As of June 30, 2017 and December 31, 2016, the Company’s inventories were composed of:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Audited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,423</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,243</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work in progress</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,971</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,292</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished products</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,753</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,014</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,147</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,549</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> A summary of the status of the Company’s option plans as of June 30, 2017 and changes during the period then ended is presented below:    <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30, 2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of options</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">exercise <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at beginning of year</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,377,354</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.76</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,757,238</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.25</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(639,902</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.13</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited and cancelled</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(205,370</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.65</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of June 30, 2017</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,289,320</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.88</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable options</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,722,358</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.49</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,289,320</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.88</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> A summary of the status of the Company’s RSUs as of June 30, 2017 and changes during the period then ended is presented below:    <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.76%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.58%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30, 2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.76%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.76%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of RSUs</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">grant date fair value <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested at beginning of year</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,661,619</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.64</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.76%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited and cancelled</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.76%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested as of June 30, 2017</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,661,619</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.64</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> The fair value of equity-based awards was estimated using the Black-Scholes option-pricing model for all grants with the following underlying assumptions:    <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="4" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.8%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:16.02%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="4" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.8%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Audited</td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Option Plans</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5-6.25</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.25</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.25</td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.74%-59.15%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.80%-61.65%</td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58.40%-61.70%</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.99%-2.23%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23%-1.88%</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23%-1.88%</td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend yield</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00%</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ESPP</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.50</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.42</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82.00%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.45%</td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.62%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.40%</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend yield</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00%</td> </tr> </table></div>  </div>

<div> The total non-cash share-based compensation expense related to all of the Company’s equity-based awards recognized for the three and six months ended June 30, 2017 and 2016 and the year ended December 31, 2016 was:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three months ended June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Audited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenues</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">131</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">274</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">311</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research, development and clinical trials</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">811</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">839</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,673</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,602</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,155</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,735</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,349</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,390</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,639</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,111</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,893</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,279</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,794</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,541</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,552</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total share-based compensation expense</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,570</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,637</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,131</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,093</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.62%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,441</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> The following table presents long-lived assets by location:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Audited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,096</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,981</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Switzerland</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,358</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,346</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Israel</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,777</td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,915</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Others</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">451</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">378</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,682</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,620</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> The Company’s revenues by geographic region, based on the customer’s location, are summarized as follows:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.4%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three months ended June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.4%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.4%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.4%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unaudited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Audited</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,367</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,122</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60,526</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,135</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.7%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,771</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EMEA (*)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,891</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,797</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,559</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,775</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,028</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Japan</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">171</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,376</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,919</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,256</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,972</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82,888</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.7%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(*) including Germany</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,817</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,766</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,216</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.6%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,659</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.7%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,799</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

-670000

104106000

119825000

5423000

5243000

10971000

8292000

8753000

12014000

The facilities of the Company are leased under various operating lease agreements for periods ending no later than 2024. 2024 The Company also leases motor vehicles under various operating leases, which expire on various dates, the latest of which is in 2020. 2020

1051000

807000

1214000 955000

1417097

3.59

801845

639902

639902 6498

P4Y

P10Y

P3Y

9824964

11377354

4757238

205370

15289320

6722358

15289320

9.76

9.25

2.13

12.65

9.88

7.49

9.88

1661619

9.64

2328171

209355

P6Y3M

P5Y6M

P6Y3M

0.5674

0.5980

0.5840

0.5915

0.6165

0.6170

0.0199

0.0123

0.0223

0.0188

0.0000

P6M

P5M1D

0.8200

0.7045

0.0062

0.0040

0.0000

131000

170000

274000

311000

623000

811000

839000

1673000

1602000

3155000

1735000

1349000

2390000

2639000

5111000

4893000

3279000

7794000

6541000

12552000

7570000

5637000

12131000

11093000

21441000

12096000

11981000

4358000

4346000

1777000

1915000

451000

378000

18682000

18620000

31367000

16122000

60526000

28135000

72771000

6891000

1797000

12559000

2775000

10028000

118000

171000

62000

89000

6817000

1766000

12216000

2659000

9799000

EX-101.SCH 8 nvcr-20170630.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - CONSOLIDATED BALANCE SHEETS link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY link:calculationLink link:presentationLink link:definitionLink 100060 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Organization and Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Short-Term Investments link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Inventories link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Commitments and Contingent Liabilities link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Share Capital link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Equity Incentive Plans link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Supplemental Information link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Organization and Basis of Presentation (Policies) link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Inventories (Tables) link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Equity Incentive Plans (Tables) link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Supplemental Information (Tables) link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Organization and Basis of Presentation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Short-Term Investments - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Inventories - Schedule of Inventories (Details) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Commitments and Contingent Liabilities - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Share Capital - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Equity Incentive Plans - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Equity Incentive Plans - Schedule of Stock Option Plan (Details) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Equity Incentive Plans - Schedule of RSU's (Details) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Equity Incentive Plans - Schedule of Fair Value of Equity Based Awards Using Black-Scholes Option Pricing Model (Details) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Equity Incentive Plans - Schedule of Non-cash Share-Based Compensation Expenses Related to Company's Equity-Based Awards (Details) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Supplemental Information - Schedule of Long-Lived Assets by Location (Details) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Supplemental Information - Schedule of Revenues by Geographic Region (Details) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Supplemental Information - Schedule of Revenues by Geographic Region (Parenthetical) (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 9 nvcr-20170630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 nvcr-20170630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 nvcr-20170630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Document document and entity information. Document Document And Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Receivables and prepaid expenses. Field equipment, net, noncurrent. Severance pay fund noncurrent. Employee related liabilities noncurrent. Statement Of Financial Position [Abstract] ASSETS Assets [Abstract] CURRENT ASSETS: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Short-term investments Held To Maturity Securities Current Restricted cash Restricted Cash Current Trade receivables Accounts Receivable Net Current Receivables and prepaid expenses Receivables And Prepaid Expenses Inventories Inventory Net Total current assets Assets Current LONG-TERM ASSETS: Assets Noncurrent [Abstract] Property and equipment, net Property Plant And Equipment Net Field equipment, net Field Equipment Net Noncurrent Severance pay fund Severance Pay Fund Noncurrent Other long-term assets Other Assets Noncurrent Total long-term assets Assets Noncurrent TOTAL ASSETS Assets LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities And Stockholders Equity [Abstract] CURRENT LIABILITIES: Liabilities Current [Abstract] Trade payables Accounts Payable Trade Current Other payables and accrued expenses Other Accounts Payable And Accrued Liabilities Total current liabilities Liabilities Current LONG-TERM LIABILITIES: Liabilities Noncurrent [Abstract] Long-term loan, net of discount and issuance costs Long Term Debt Noncurrent Employee benefit liabilities Employee Related Liabilities Non Current Other long-term liabilities Other Liabilities Noncurrent Total long-term liabilities Liabilities Noncurrent TOTAL LIABILITIES Liabilities COMMITMENTS AND CONTINGENCIES Commitments And Contingencies SHAREHOLDERS' EQUITY: Stockholders Equity [Abstract] Ordinary shares no par value, unlimited shares authorized; issued and outstanding: 88,630,205 shares and 87,066,446 shares at June 30, 2017 (unaudited) and December 31, 2016, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated deficit Retained Earnings Accumulated Deficit Total shareholders' equity Stockholders Equity TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities And Stockholders Equity Common stock, par value Common Stock No Par Value Common stock, shares authorized Common Stock Shares Authorized Unlimited Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Income Statement [Abstract] Net revenues Sales Revenue Net Cost of revenues Cost Of Revenue Impairment of field equipment Production Related Impairments Or Charges Gross profit Gross Profit Operating costs and expenses: Operating Expenses [Abstract] Research, development and clinical trials Research And Development Expense Sales and marketing Selling And Marketing Expense General and administrative General And Administrative Expense Total operating costs and expenses Operating Expenses Operating loss Operating Income Loss Financial expenses, net Interest And Debt Expense Loss before income tax expense Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income tax expense Income Tax Expense Benefit Net loss Net Income Loss Basic and diluted net loss per ordinary share Earnings Per Share Basic And Diluted Weighted average number of ordinary shares used in computing basic and diluted net loss per share Weighted Average Number Of Share Outstanding Basic And Diluted Statement Of Income And Comprehensive Income [Abstract] Net loss Other comprehensive income (loss), net of tax : Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Change in foreign currency translation adjustments Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Pension benefit plan Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax Total comprehensive loss Comprehensive Income Net Of Tax Stock issued during period shares exercise of options and warrants. Stock issued during period value exercise of options and warrants. Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Ordinary Shares Common Stock [Member] Additional Paid-in Capital Additional Paid In Capital [Member] Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Income [Member] Accumulated Deficit Retained Earnings [Member] Statement [Line Items] Statement [Line Items] Balance Balance (in shares) Shares Outstanding Share-based compensation to employees Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Exercise of options and warrants Stock Issued During Period Value Exercise Of Options And Warrants Exercise of options and warrants (in shares) Stock Issued During Period Shares Exercise Of Options And Warrants Cumulative effect adjustment resulting from ASU2016-09 adoption (see Note 1) Cumulative Effect On Retained Earnings Net Of Tax1 Issuance of shares in connection with employee stock purchase plan Stock Issued During Period Value Employee Stock Purchase Plan Issuance of shares in connection with employee stock purchase plan(in shares) Stock Issued During Period Shares Employee Stock Purchase Plans Tax benefit from share-based award activity Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation Other comprehensive loss, net of tax benefit of $38 and $1 for the years December 2016 and June 2017 Other Comprehensive Income Loss Net Of Tax Balance Balance (in shares) Other comprehensive loss, tax benefit Other Comprehensive Income Loss Tax Increase (decrease) in receivables and prepaid expenses. Payments to acquire of field equipment. Cash paid during the period for. Statement Of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided By Used In Operating Activities Continuing Operations [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation and amortization Depreciation And Amortization Asset write-downs and impairment of field equipment Asset Impairment Charges Increase in accrued interest expense Increase Decrease In Interest Payable Net Share-based compensation to employees Share Based Compensation Excess tax benefits from share-based award activity Excess Tax Benefit From Share Based Compensation Operating Activities Increase in trade receivables Increase Decrease In Accounts Receivable Amortization of discount (premium) Amortization Of Debt Discount Premium Decrease (increase) in receivables and prepaid expenses Increase Decrease In Receivables And Prepaid Expenses Decrease (Increase) in inventories Increase Decrease In Inventories Increase in other long-term assets Increase Decrease In Other Noncurrent Assets Increase (decrease) in trade payables Increase Decrease In Accounts Payable Trade Increase in other payables and accrued expenses Increase Decrease In Other Accounts Payable And Accrued Liabilities Increase in employee benefit liabilities, net Increase Decrease In Employee Related Liabilities Increase in other long-term liabilities Increase Decrease In Other Noncurrent Liabilities Net cash used in operating activities Net Cash Provided By Used In Operating Activities Continuing Operations Cash flows from investing activities: Net Cash Provided By Used In Investing Activities Continuing Operations [Abstract] Purchase of property and equipment Payments To Acquire Property Plant And Equipment Purchase of field equipment Payments To Acquire Of Field Equipment increase in restricted cash Increase In Restricted Cash Proceeds from maturity of short-term investments Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities Purchase of short-term investments Payments To Acquire Held To Maturity Securities Net cash provided by (used in) investing activities Net Cash Provided By Used In Investing Activities Continuing Operations Cash flows from financing activities: Net Cash Provided By Used In Financing Activities Continuing Operations [Abstract] Proceeds from issuance of shares, net Proceeds From Issuance Of Common Stock Proceeds from long-term loan, net Proceeds From Issuance Of Long Term Debt Excess tax benefits from share-based award activity Excess Tax Benefit From Share Based Compensation Financing Activities Repayment of other long-term loan Repayments Of Other Long Term Debt Exercise of options and warrants Proceeds From Issuance Or Sale Of Equity Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Continuing Operations Effect of exchange rate changes on cash and cash equivalents Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations Decrease in cash and cash equivalents Cash And Cash Equivalents Period Increase Decrease Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Cash paid during the period for: Cash Paid During Period For [Abstract] Income taxes Income Taxes Paid Net Interest Interest Paid Organization Consolidation And Presentation Of Financial Statements [Abstract] Organization and Basis of Presentation Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Marketable Securities Current [Abstract] Short-Term Investments Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block] Inventory Disclosure [Abstract] Inventories Inventory Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingent Liabilities Commitments And Contingencies Disclosure [Text Block] Share Based Compensation Allocation And Classification In Financial Statements [Abstract] Share Capital Shareholders Equity And Share Based Payments [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Equity Incentive Plans Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Geographic Areas Long Lived Assets [Abstract] Supplemental Information Segment Reporting Disclosure [Text Block] Recently Adopted Accounting Pronouncements New Accounting Pronouncements Policy Policy [Text Block] Schedule of Inventories Schedule Of Inventory Current Table [Text Block] Schedule of Stock Option Plans Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Schedule of RSU's Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block] Schedule of Fair Value of Equity Based Awards Using Black-Scholes Option Pricing Model Disclosure Of Share Based Compensation Arrangements By Share Based Payment Award [Text Block] Schedule of Non-cash Share-based Compensation Expense Related to Company's Equity-Based Awards Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Schedule of Long-Lived Assets by Location Long Lived Assets By Geographic Areas Table [Text Block] Schedule of Revenues by Geographic Region Revenue From External Customers By Geographic Areas Table [Text Block] Organization and basis of presentation. Organization and basis of presentation. Organization And Basis Of Presentation [Table] Organization And Basis Of Presentation [Table] Adjustments for New Accounting Pronouncements Adjustments For New Accounting Pronouncements [Axis] Type of Adoption Type Of Adoption [Member] Accounting Standards Update 2016-09 [Member] Accounting Standards Update201609 [Member] Organization and Basis of Presentation [Line Items] Organization And Basis Of Presentation [Line Items] Cumulative deficit effect adjustment resulting from ASU 2016-09 adoption New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1 Investments Debt And Equity Securities [Abstract] Estimated fair value of short-term investments Held To Maturity Securities Fair Value Raw materials Inventory Raw Materials Net Of Reserves Work in progress Inventory Work In Process Net Of Reserves Finished products Inventory Finished Goods Net Of Reserves Total Operating lease expiration description. Operating lease agreement expiration period. Loss Contingencies [Table] Loss Contingencies [Table] Range Range [Axis] Range Range [Member] Maximum Maximum [Member] Property, Plant and Equipment, Type Property Plant And Equipment By Type [Axis] Property, Plant and Equipment, Type Property Plant And Equipment Type [Domain] Motor Vehicles Vehicles [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Operating lease expiration description Operating Lease Expiration Description Operating lease agreements, expiration year Operating Lease Agreement Expiration Period Operating lease and other contractual commitments. Pledged bank deposits Deposits Assets Operating lease and other contractual commitments Operating Lease And Other Contractual Commitments Ordinary shares issued upon option exercise. Class Of warrant number Of securities called by warrants exercised for cash. Share capital. Schedule of share capital. Schedule Of Share Capital [Table] Schedule Of Share Capital [Table] Warrant Warrant [Member] Shareholders' Equity Class Shareholders Equity Class [Axis] Fair Value by Shareholders' Equity Class Fair Value By Shareholders Equity Class [Domain] Warrants Not Settleable in Cash Warrants Not Settleable In Cash [Member] Share Capital [Line Items] Share Capital [Line Items] The Number of ordinary shares that originally could be purchased by exercise of warrants Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Warrants exercise price Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Number of shares issued upon the exercise of warrants Stock Issued During Period Shares New Issues Options exercised for cash Stock Issued During Period Shares Stock Options Exercised Ordinary shares issued upon option exercise Ordinary Shares Issued Upon Option Exercise The Number of ordinary shares that originally could be purchased by exercise of warrants in cash Class Of Warrant Number Of Securities Called By Warrants Exercised For Cash Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] Two thousand fifteen plan. 2015 Plan Two Thousand Fifteen Plan [Member] EX-101.PRE 12 nvcr-20170630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2017	Jul. 20, 2017
Document Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q2
Trading Symbol	NVCR
Entity Registrant Name	Novocure Ltd
Entity Central Index Key	0001645113
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		89,002,575

XML 14 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
CURRENT ASSETS:
Cash and cash equivalents	$ 80,190	$ 99,780
Short-term investments	104,186	119,854
Restricted cash	1,537	267
Trade receivables	13,888	6,339
Receivables and prepaid expenses	11,544	10,084
Inventories	25,147	25,549
Total current assets	236,492	261,873
LONG-TERM ASSETS:
Property and equipment, net	9,621	9,812
Field equipment, net	9,061	8,808
Severance pay fund	102	88
Other long-term assets	1,766	1,500
Total long-term assets	20,550	20,208
TOTAL ASSETS	257,042	282,081
CURRENT LIABILITIES:
Trade payables	13,161	18,356
Other payables and accrued expenses	22,010	18,526
Total current liabilities	35,171	36,882
LONG-TERM LIABILITIES:
Long-term loan, net of discount and issuance costs	96,765	96,231
Employee benefit liabilities	2,679	2,590
Other long-term liabilities	4,882	4,033
Total long-term liabilities	104,326	102,854
TOTAL LIABILITIES	139,497	139,736
COMMITMENTS AND CONTINGENCIES	0	0
SHAREHOLDERS' EQUITY:
Ordinary shares no par value, unlimited shares authorized; issued and outstanding: 88,630,205 shares and 87,066,446 shares at June 30, 2017 (unaudited) and December 31, 2016, respectively	0	0
Additional paid-in capital	679,099	664,154
Accumulated other comprehensive loss	(1,739)	(1,883)
Accumulated deficit	(559,815)	(519,926)
Total shareholders' equity	117,545	142,345
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 257,042	$ 282,081

XML 15 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Statement Of Financial Position [Abstract]
Common stock, par value
Common stock, shares authorized	Unlimited	Unlimited
Common stock, shares issued	88,630,205	87,066,446
Common stock, shares outstanding	88,630,205	87,066,446

XML 16 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Income Statement [Abstract]
Net revenues	$ 38,376	$ 17,919	$ 73,256	$ 30,972	$ 82,888
Cost of revenues	13,152	9,797	24,816	17,779	39,870
Impairment of field equipment		6,412		6,412	6,412
Gross profit	25,224	1,710	48,440	6,781	36,606
Operating costs and expenses:
Research, development and clinical trials	9,371	11,318	18,782	22,763	41,467
Sales and marketing	16,360	14,598	31,116	27,906	59,449
General and administrative	15,023	13,031	27,445	25,287	51,007
Total operating costs and expenses	40,754	38,947	77,343	75,956	151,923
Operating loss	(15,530)	(37,237)	(28,903)	(69,175)	(115,317)
Financial expenses, net	(2,183)	(555)	(4,629)	(1,104)	(6,147)
Loss before income tax expense	(17,713)	(37,792)	(33,532)	(70,279)	(121,464)
Income tax expense	3,461	2,820	5,687	5,770	10,381
Net loss	$ (21,174)	$ (40,612)	$ (39,219)	$ (76,049)	$ (131,845)
Basic and diluted net loss per ordinary share	$ (0.24)	$ (0.48)	$ (0.45)	$ (0.90)	$ (1.54)
Weighted average number of ordinary shares used in computing basic and diluted net loss per share	88,218,868	85,274,683	87,835,926	84,843,028	85,558,448

XML 17 R5.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Statement Of Income And Comprehensive Income [Abstract]
Net loss	$ (21,174)	$ (40,612)	$ (39,219)	$ (76,049)	$ (131,845)
Other comprehensive income (loss), net of tax :
Change in foreign currency translation adjustments	1	56	10	56	10
Pension benefit plan	183	235	134	(235)	(388)
Total comprehensive loss	$ (20,990)	$ (40,321)	$ (39,075)	$ (76,228)	$ (132,223)

XML 18 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Ordinary Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at Dec. 31, 2015	$ 250,820		$ 640,406	$ (1,505)	$ (388,081)
Balance (in shares) at Dec. 31, 2015		83,778,581
Share-based compensation to employees	21,441		21,441
Exercise of options and warrants	993		993
Exercise of options and warrants (in shares)		3,195,477
Issuance of shares in connection with employee stock purchase plan	616		616
Issuance of shares in connection with employee stock purchase plan(in shares)		92,388
Tax benefit from share-based award activity	698		698
Other comprehensive loss, net of tax benefit of $38 and $1 for the years December 2016 and June 2017	(378)			(378)
Net loss	(131,845)				(131,845)
Balance at Dec. 31, 2016	142,345		664,154	(1,883)	(519,926)
Balance (in shares) at Dec. 31, 2016		87,066,446
Share-based compensation to employees	12,131		12,131
Exercise of options and warrants	1,363		1,363
Exercise of options and warrants (in shares)		1,446,792
Cumulative effect adjustment resulting from ASU2016-09 adoption (see Note 1)			670		(670)
Issuance of shares in connection with employee stock purchase plan	781		781
Issuance of shares in connection with employee stock purchase plan(in shares)		116,967
Other comprehensive loss, net of tax benefit of $38 and $1 for the years December 2016 and June 2017	144			144
Net loss	(39,219)				(39,219)
Balance at Jun. 30, 2017	$ 117,545		$ 679,099	$ (1,739)	$ (559,815)
Balance (in shares) at Jun. 30, 2017		88,630,205

XML 19 R7.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Statement Of Stockholders Equity [Abstract]
Other comprehensive loss, tax benefit	$ 29	$ 38

XML 20 R8.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Cash flows from operating activities:
Net loss	$ (21,174)	$ (40,612)	$ (39,219)	$ (76,049)	$ (131,845)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,811	1,407	3,471	2,510	5,652
Asset write-downs and impairment of field equipment	59	6,425	134	6,430	6,446
Increase in accrued interest expense		(637)
Share-based compensation to employees	7,570	5,637	12,131	11,093	22,139
Excess tax benefits from share-based award activity					(698)
Increase in trade receivables	(2,064)		(7,550)		(6,339)
Amortization of discount (premium)	103	(39)	209	(56)	155
Decrease (increase) in receivables and prepaid expenses	3,354	(1,672)	(1,461)	(2,208)	243
Decrease (Increase) in inventories	803	(4,769)	403	(7,621)	(11,955)
Increase in other long-term assets	(38)	(111)	(294)	(278)	(692)
Increase (decrease) in trade payables	(1,638)	2,321	(5,195)	4,144	1,601
Increase in other payables and accrued expenses	4,888	2,399	3,478	756	6,647
Increase in employee benefit liabilities, net	130	32	239	270	97
Increase in other long-term liabilities	321	225	871	638	957
Net cash used in operating activities	(5,875)	(29,394)	(32,783)	(60,371)	(107,592)
Cash flows from investing activities:
Purchase of property and equipment	(376)	(2,338)	(1,407)	(3,340)	(5,674)
Purchase of field equipment	(859)	(4,274)	(2,261)	(6,100)	(11,990)
increase in restricted cash	(1)	(13)	(1,269)	(12)	(180)
Proceeds from maturity of short-term investments	60,000		120,000	150,000	270,000
Purchase of short-term investments	(59,352)		(104,006)	(119,728)	(239,341)
Net cash provided by (used in) investing activities	(588)	(6,625)	11,057	20,820	12,815
Cash flows from financing activities:
Proceeds from issuance of shares, net	781		781		616
Proceeds from long-term loan, net	19	17	19	17	72,887
Excess tax benefits from share-based award activity					698
Repayment of other long-term loan	(19)	(19)	(37)	(35)	(70)
Exercise of options and warrants	1,286	904	1,363	961	993
Net cash provided by financing activities	2,067	902	2,126	943	75,124
Effect of exchange rate changes on cash and cash equivalents	(1)	56	10	56	10
Decrease in cash and cash equivalents	(4,397)	(35,061)	(19,590)	(38,552)	(19,643)
Cash and cash equivalents at the beginning of the period	84,587	115,932	99,780	119,423	119,423
Cash and cash equivalents at the end of the period	80,190	80,871	80,190	80,871	99,780
Cash paid during the period for:
Income taxes	1,500	1,587	4,902	3,169	9,447
Interest	$ 2,533	$ 1,269	$ 5,041	$ 1,933	$ 6,595

XML 21 R9.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation	6 Months Ended
Organization and Basis of Presentation	Jun. 30, 2017
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization and Basis of Presentation	NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION Organization. NovoCure Limited (including its consolidated subsidiaries, the “Company”) was incorporated in the Bailiwick of Jersey and is principally engaged in the development, manufacture and commercialization of Tumor Treating Fields (“TTFields”) for the treatment of solid tumors. The Company has regulatory approvals and clearances in certain countries for Optune, its first TTFields delivery system, to treat adult patients with glioblastoma (“GBM”). Financial statement preparation. The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries, and intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. These consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “2016 10-K”) filed with the Securities and Exchange Commission (the “SEC”) on February 23, 2017. The significant accounting policies applied in the audited annual consolidated financial statements of the Company as disclosed in the 2016 10-K are applied consistently in these unaudited interim consolidated financial statements, except as noted below: Recently Adopted Accounting Pronouncements. In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendments in ASU 2016-09 affect all entities that issue share-based payment awards to their employees and involve multiple aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted ASU 2016-09 during the quarter ended March 31, 2017, at which time it changed its accounting policy to account for forfeitures as they occur. The change was applied on a modified retrospective basis with a cumulative effect adjustment to accumulated deficit of $670 as of January 1, 2017. In addition, excess tax benefits for share-based payments are now presented as an operating activity in the statements of cash flows rather than financing activity. The changes have been applied prospectively in accordance with the ASU and prior periods have not been adjusted. Recent Accounting Pronouncements. In May 2014, FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) (ASU 2014-09), which amends the existing accounting standards for revenue recognition. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delays the effective date of ASU 2014-09 by one year. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. The new revenue recognition standard will be effective in the first quarter of 2018, with the option to adopt it in the first quarter of 2017. The Company currently anticipates adopting the new standard effective January 1, 2018. The new standard also permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective method). The Company currently anticipates adopting the standard using the modified retrospective method. While the Company is still in the process of completing its assessment on the impact this guidance will have on its consolidated financial statements and related disclosures, the Company expects that the most significant impact relates to the accounting for revenue transactions whereby there is variable consideration. In April 2016, FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. ASU 2016-10 covers two specific topics: performance obligations and licensing. This amendment includes guidance on immaterial promised goods or services, shipping or handling activities, separately identifiable performance obligations, functional or symbolic intellectual property licenses, sales-based and usage-based royalties, license restrictions (time, use, geographical) and licensing renewals. In addition, in May 2016, FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, which is intended to not change the core principle of the guidance in Topic 606, but rather affect only the narrow aspects of Topic 606 by reducing the potential for diversity in practice at initial application and by reducing the cost and complexity of applying Topic 606 both at transition and on an ongoing basis. The Company is currently evaluating the impact of the adoption of both revenue standards on its consolidated financial statements. In February 2016, FASB issued ASU 2016-02-Leases (ASC 842), which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of their classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 supersedes the previous leases standard, ASC 840. The standard is effective on January 1, 2019, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements. In May 2017, FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting. ASU 2017-09 provides clarification on when modification accounting should be used for changes to the terms or conditions of a share-based payment award. This ASU does not change the accounting for modifications but clarifies that modification accounting guidance should only be applied if there is a change to the value, vesting conditions, or award classification and would not be required if the changes are considered non-substantive. The Company is evaluating the impact of ASU 2017-09.

XML 22 R10.htm IDEA: XBRL DOCUMENT

Short-Term Investments	6 Months Ended
Short-Term Investments	Jun. 30, 2017
Marketable Securities Current [Abstract]
Short-Term Investments	NOTE 2: SHORT-TERM INVESTMENTS The Company invests in marketable U.S. Treasury Bills (“T-bills”) that are classified as held-to-maturity securities. The amortized cost and recorded basis of the T-bills are presented as short-term investments in the amount of $104,186 and $119,854 as of June 30, 2017 and December 31, 2016, respectively, and their estimated fair value as of June 30, 2017 and December 31, 2016 was $104,106 and $119,825, respectively.

XML 23 R11.htm IDEA: XBRL DOCUMENT

Inventories

6 Months Ended

Jun. 30, 2017

Inventory Disclosure [Abstract]

Inventories

NOTE 3: INVENTORIES

	June 30,		December 31,
	2017		2016
	Unaudited		Audited
Raw materials	$	5,423	$	5,243
Work in progress		10,971		8,292
Finished products		8,753		12,014
Total	$	25,147	$	25,549

XML 24 R12.htm IDEA: XBRL DOCUMENT

Commitments and Contingent Liabilities	6 Months Ended
Commitments and Contingent Liabilities	Jun. 30, 2017
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingent Liabilities	NOTE 4: COMMITMENTS AND CONTINGENT LIABILITIES The facilities of the Company are leased under various operating lease agreements for periods ending no later than 2024. The Company also leases motor vehicles under various operating leases, which expire on various dates, the latest of which is in 2020. As of June 30, 2017 and December 31, 2016, the Company pledged bank deposits of $1,051 and $807, respectively, to cover bank guarantees in respect of its leases of operating facilities and obtained guarantees by the bank for the fulfillment of the Company’s lease and other contractual commitments of $1,214 and $955, respectively. In January 2017, two putative class action lawsuits were filed against the Company, its directors and certain of its officers, as well as the underwriters in the Company’s October 2015 initial public offering. The complaints, which purport to be brought on behalf of a class of persons and/or entities who purchased or otherwise acquired ordinary shares of the Company pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s initial public offering, allege material misstatements and/or omissions in the Company’s initial public offering materials in alleged violation of the federal securities laws and seek compensatory damages, among other remedies. The two actions have been consolidated and the plaintiffs filed a consolidated amended complaint on May 31, 2017. The court granted the defendants’ motion to bifurcate the motion to dismiss into two stages: a threshold motion to dismiss for lack of personal jurisdiction, lack of subject matter jurisdiction, and insufficient process and service of process, due on July 31, 2017; and, if the matter is not dismissed following that threshold motion, a subsequent merits motion to dismiss regarding whether the allegations in the amended complaint state a claim under the securities laws. The Company believes that the amended complaint is without merit and plans to defend the consolidated lawsuits vigorously. The Company has not accrued any amounts in respect of these lawsuits, as a liability is not probable and the amount of any potential liability cannot be reasonably estimated.

XML 25 R13.htm IDEA: XBRL DOCUMENT

Share Capital	6 Months Ended
Share Capital	Jun. 30, 2017
Share Based Compensation Allocation And Classification In Financial Statements [Abstract]
Share Capital	NOTE 5: SHARE CAPITAL For the six months ended June 30, 2017, warrants to purchase 1,417,097 ordinary shares with an exercise price of $3.59 per share were cashlessly exercised, resulting in the issuance of 801,845 ordinary shares. Also, warrants to purchase 6,498 ordinary shares with an exercise price of $3.59 per share were exercised for cash. For the six months ended June 30, 2017, options to purchase 639,902 ordinary shares were exercised for cash, resulting in the issuance of 639,902 ordinary shares.

XML 26 R14.htm IDEA: XBRL DOCUMENT

Equity Incentive Plans

6 Months Ended

Jun. 30, 2017

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Equity Incentive Plans

NOTE 6: EQUITY INCENTIVE PLANS

A summary of the status of the Company’s option plans as of June 30, 2017 and changes during the period then ended is presented below:

	Six months ended June 30, 2017
	Unaudited
	Number of options			Weighted average exercise price
Outstanding at beginning of year		11,377,354		$	9.76
Granted		4,757,238			9.25
Exercised		(639,902	)		2.13
Forfeited and cancelled		(205,370	)		12.65
Outstanding as of June 30, 2017		15,289,320			9.88

Exercisable options		6,722,358			7.49

Vested and expected to vest		15,289,320		$	9.88

A summary of the status of the Company’s RSUs as of June 30, 2017 and changes during the period then ended is presented below:

	Six months ended June 30, 2017
	Unaudited
	Number of RSUs		Weighted average grant date fair value price
Unvested at beginning of year		-	$	-
Granted		1,661,619		9.64
Vested		-		-
Forfeited and cancelled		-		-
Unvested as of June 30, 2017		1,661,619	$	9.64

In September 2015, the Company adopted an employee share purchase plan (“ESPP”) to encourage and enable eligible employees to acquire ownership of the Company’s ordinary shares purchased through accumulated payroll deductions on an after-tax basis. In the United States, the ESPP is intended to be an “employee stock purchase plan” within the meaning of Section 423 of the Internal Revenue Code and the provisions of the ESPP will be construed in a manner consistent with the requirements of such section. The Company began its offerings under the ESPP on August 1, 2016. As of June 30, 2017, 2,328,171 ordinary shares were available to be purchased by eligible employees under the ESPP and 209,355 shares had been issued under the ESPP.

The fair value of equity-based awards was estimated using the Black-Scholes option-pricing model for all grants with the following underlying assumptions:

	Six months ended June 30,			Year ended December 31,
	2017	2016		2016
	Unaudited			Audited
Stock Option Plans
Expected term (years)	5.5-6.25	6.25		6.25
Expected volatility	56.74%-59.15%	59.80%-61.65%		58.40%-61.70%
Risk-free interest rate	1.99%-2.23%	1.23%-1.88%		1.23%-1.88%
Dividend yield	0.00%	0.00%		0.00%
ESPP
Expected term (years)	0.50		-	0.42
Expected volatility	82.00%		-	70.45%
Risk-free interest rate	0.62%		-	0.40%
Dividend yield	0.00%		-	0.00%

	Three months ended June 30,				Six months ended June 30,				Year ended December 31,
	2017		2016		2017		2016		2016
	Unaudited				Unaudited				Audited
Cost of revenues	$	131	$	170	$	274	$	311	$	623
Research, development and clinical trials		811		839		1,673		1,602		3,155
Sales and marketing		1,735		1,349		2,390		2,639		5,111
General and administrative		4,893		3,279		7,794		6,541		12,552
Total share-based compensation expense	$	7,570	$	5,637	$	12,131	$	11,093	$	21,441

XML 27 R15.htm IDEA: XBRL DOCUMENT

Supplemental Information

6 Months Ended

Jun. 30, 2017

Geographic Areas Long Lived Assets [Abstract]

Supplemental Information

NOTE 7: SUPPLEMENTAL INFORMATION

The Company operates in a single reportable segment.

The following table presents long-lived assets by location:

	June 30,		December 31,
	2017		2016
	Unaudited		Audited
United States	$	12,096	$	11,981
Switzerland		4,358		4,346
Israel		1,777		1,915
Others	451			378
Total	$	18,682	$	18,620

The Company’s revenues by geographic region, based on the customer’s location, are summarized as follows:

	Three months ended June 30,				Six months ended June 30,				Year ended December 31,
	2017		2016		2017		2016		2016
	Unaudited				Unaudited				Audited
United States	$	31,367	$	16,122	$	60,526	$	28,135	$	72,771
EMEA (*)		6,891		1,797		12,559		2,775		10,028
Japan		118		-		171		62		89
Total	$	38,376	$	17,919	$	73,256	$	30,972	$	82,888

(*) including Germany	$	6,817	$	1,766		12,216		2,659	$	9,799

XML 28 R16.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation (Policies)	6 Months Ended
Organization and Basis of Presentation (Policies)	Jun. 30, 2017
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements. In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09, Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendments in ASU 2016-09 affect all entities that issue share-based payment awards to their employees and involve multiple aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted ASU 2016-09 during the quarter ended March 31, 2017, at which time it changed its accounting policy to account for forfeitures as they occur. The change was applied on a modified retrospective basis with a cumulative effect adjustment to accumulated deficit of $670 as of January 1, 2017. In addition, excess tax benefits for share-based payments are now presented as an operating activity in the statements of cash flows rather than financing activity. The changes have been applied prospectively in accordance with the ASU and prior periods have not been adjusted. Recent Accounting Pronouncements. In May 2014, FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) (ASU 2014-09), which amends the existing accounting standards for revenue recognition. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delays the effective date of ASU 2014-09 by one year. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. The new revenue recognition standard will be effective in the first quarter of 2018, with the option to adopt it in the first quarter of 2017. The Company currently anticipates adopting the new standard effective January 1, 2018. The new standard also permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective method). The Company currently anticipates adopting the standard using the modified retrospective method. While the Company is still in the process of completing its assessment on the impact this guidance will have on its consolidated financial statements and related disclosures, the Company expects that the most significant impact relates to the accounting for revenue transactions whereby there is variable consideration. In April 2016, FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. ASU 2016-10 covers two specific topics: performance obligations and licensing. This amendment includes guidance on immaterial promised goods or services, shipping or handling activities, separately identifiable performance obligations, functional or symbolic intellectual property licenses, sales-based and usage-based royalties, license restrictions (time, use, geographical) and licensing renewals. In addition, in May 2016, FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, which is intended to not change the core principle of the guidance in Topic 606, but rather affect only the narrow aspects of Topic 606 by reducing the potential for diversity in practice at initial application and by reducing the cost and complexity of applying Topic 606 both at transition and on an ongoing basis. The Company is currently evaluating the impact of the adoption of both revenue standards on its consolidated financial statements. In February 2016, FASB issued ASU 2016-02-Leases (ASC 842), which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of their classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 supersedes the previous leases standard, ASC 840. The standard is effective on January 1, 2019, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements. In May 2017, FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting. ASU 2017-09 provides clarification on when modification accounting should be used for changes to the terms or conditions of a share-based payment award. This ASU does not change the accounting for modifications but clarifies that modification accounting guidance should only be applied if there is a change to the value, vesting conditions, or award classification and would not be required if the changes are considered non-substantive. The Company is evaluating the impact of ASU 2017-09.

XML 29 R17.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

6 Months Ended

Jun. 30, 2017

Inventory Disclosure [Abstract]

Schedule of Inventories

	June 30,		December 31,
	2017		2016
	Unaudited		Audited
Raw materials	$	5,423	$	5,243
Work in progress		10,971		8,292
Finished products		8,753		12,014
Total	$	25,147	$	25,549

XML 30 R18.htm IDEA: XBRL DOCUMENT

Equity Incentive Plans (Tables)

6 Months Ended

Jun. 30, 2017

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Stock Option Plans

A summary of the status of the Company’s option plans as of June 30, 2017 and changes during the period then ended is presented below:

	Six months ended June 30, 2017
	Unaudited
	Number of options			Weighted average exercise price
Outstanding at beginning of year		11,377,354		$	9.76
Granted		4,757,238			9.25
Exercised		(639,902	)		2.13
Forfeited and cancelled		(205,370	)		12.65
Outstanding as of June 30, 2017		15,289,320			9.88

Exercisable options		6,722,358			7.49

Vested and expected to vest		15,289,320		$	9.88

Schedule of RSU's

A summary of the status of the Company’s RSUs as of June 30, 2017 and changes during the period then ended is presented below:

	Six months ended June 30, 2017
	Unaudited
	Number of RSUs		Weighted average grant date fair value price
Unvested at beginning of year		-	$	-
Granted		1,661,619		9.64
Vested		-		-
Forfeited and cancelled		-		-
Unvested as of June 30, 2017		1,661,619	$	9.64

Schedule of Fair Value of Equity Based Awards Using Black-Scholes Option Pricing Model

The fair value of equity-based awards was estimated using the Black-Scholes option-pricing model for all grants with the following underlying assumptions:

	Six months ended June 30,			Year ended December 31,
	2017	2016		2016
	Unaudited			Audited
Stock Option Plans
Expected term (years)	5.5-6.25	6.25		6.25
Expected volatility	56.74%-59.15%	59.80%-61.65%		58.40%-61.70%
Risk-free interest rate	1.99%-2.23%	1.23%-1.88%		1.23%-1.88%
Dividend yield	0.00%	0.00%		0.00%
ESPP
Expected term (years)	0.50		-	0.42
Expected volatility	82.00%		-	70.45%
Risk-free interest rate	0.62%		-	0.40%
Dividend yield	0.00%		-	0.00%

Schedule of Non-cash Share-based Compensation Expense Related to Company's Equity-Based Awards

	Three months ended June 30,				Six months ended June 30,				Year ended December 31,
	2017		2016		2017		2016		2016
	Unaudited				Unaudited				Audited
Cost of revenues	$	131	$	170	$	274	$	311	$	623
Research, development and clinical trials		811		839		1,673		1,602		3,155
Sales and marketing		1,735		1,349		2,390		2,639		5,111
General and administrative		4,893		3,279		7,794		6,541		12,552
Total share-based compensation expense	$	7,570	$	5,637	$	12,131	$	11,093	$	21,441

XML 31 R19.htm IDEA: XBRL DOCUMENT

Supplemental Information (Tables)

6 Months Ended

Jun. 30, 2017

Geographic Areas Long Lived Assets [Abstract]

Schedule of Long-Lived Assets by Location

The following table presents long-lived assets by location:

	June 30,		December 31,
	2017		2016
	Unaudited		Audited
United States	$	12,096	$	11,981
Switzerland		4,358		4,346
Israel		1,777		1,915
Others	451			378
Total	$	18,682	$	18,620

Schedule of Revenues by Geographic Region

The Company’s revenues by geographic region, based on the customer’s location, are summarized as follows:

	Three months ended June 30,				Six months ended June 30,				Year ended December 31,
	2017		2016		2017		2016		2016
	Unaudited				Unaudited				Audited
United States	$	31,367	$	16,122	$	60,526	$	28,135	$	72,771
EMEA (*)		6,891		1,797		12,559		2,775		10,028
Japan		118		-		171		62		89
Total	$	38,376	$	17,919	$	73,256	$	30,972	$	82,888

(*) including Germany	$	6,817	$	1,766		12,216		2,659	$	9,799

XML 32 R20.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation - Additional Information (Detail) $ in Thousands	Dec. 31, 2016 USD ($)
Accounting Standards Update 2016-09 [Member]
Organization and Basis of Presentation [Line Items]
Cumulative deficit effect adjustment resulting from ASU 2016-09 adoption	$ (670)

XML 33 R21.htm IDEA: XBRL DOCUMENT

Short-Term Investments - Additional Information (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Investments Debt And Equity Securities [Abstract]
Short-term investments	$ 104,186	$ 119,854
Estimated fair value of short-term investments	$ 104,106	$ 119,825

XML 34 R22.htm IDEA: XBRL DOCUMENT

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Inventory Disclosure [Abstract]
Raw materials	$ 5,423	$ 5,243
Work in progress	10,971	8,292
Finished products	8,753	12,014
Total	$ 25,147	$ 25,549

XML 35 R23.htm IDEA: XBRL DOCUMENT

Commitments and Contingent Liabilities - Additional Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Loss Contingencies [Line Items]
Operating lease expiration description	The facilities of the Company are leased under various operating lease agreements for periods ending no later than 2024.
Pledged bank deposits	$ 1,051	$ 807
Operating lease and other contractual commitments	$ 1,214	$ 955
Motor Vehicles
Loss Contingencies [Line Items]
Operating lease expiration description	The Company also leases motor vehicles under various operating leases, which expire on various dates, the latest of which is in 2020.
Maximum
Loss Contingencies [Line Items]
Operating lease agreements, expiration year	2024
Maximum \| Motor Vehicles
Loss Contingencies [Line Items]
Operating lease agreements, expiration year	2020

XML 36 R24.htm IDEA: XBRL DOCUMENT

Share Capital - Additional Information (Details)	6 Months Ended
Share Capital - Additional Information (Details)	Jun. 30, 2017 $ / shares shares
Share Capital [Line Items]
The Number of ordinary shares that originally could be purchased by exercise of warrants	1,417,097
Warrants exercise price \| $ / shares	$ 3.59
Options exercised for cash	639,902
Ordinary shares issued upon option exercise	639,902
Warrant
Share Capital [Line Items]
The Number of ordinary shares that originally could be purchased by exercise of warrants in cash	6,498
Warrant \| Warrants Not Settleable in Cash
Share Capital [Line Items]
Number of shares issued upon the exercise of warrants	801,845

XML 37 R25.htm IDEA: XBRL DOCUMENT

Equity Incentive Plans - Additional Information (Details)	6 Months Ended
	Jun. 30, 2017 shares
ESPP
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Ordinary shares available for grants	2,328,171
Shares issued under plan	209,355
2015 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Ordinary shares available for grants	9,824,964
2015 Plan \| Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock awards granted, vesting period	4 years
Stock awards granted, expiration period	10 years
2015 Plan \| RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock awards granted, vesting period	3 years

XML 38 R26.htm IDEA: XBRL DOCUMENT

Equity Incentive Plans - Schedule of Stock Option Plan (Details)	6 Months Ended
	Jun. 30, 2017 $ / shares shares
Number of options
Number of options, Outstanding at beginning of year \| shares	11,377,354
Number of options, Granted \| shares	4,757,238
Number of options, Exercised \| shares	(639,902)
Number of options, Forfeited and cancelled \| shares	(205,370)
Number of options, Outstanding at ending of year \| shares	15,289,320
Number of options, Exercisable options \| shares	6,722,358
Number of options, Vested and expected to vest \| shares	15,289,320
Weighted average exercise price
Weighted average exercise price, Outstanding at beginning of year \| $ / shares	$ 9.76
Weighted average exercise price, Granted \| $ / shares	9.25
Weighted average exercise price, Exercised \| $ / shares	2.13
Weighted average exercise price, Forfeited and cancelled \| $ / shares	12.65
Weighted average exercise price, Outstanding at end of year \| $ / shares	9.88
Weighted average exercise price, Exercisable options \| $ / shares	7.49
Weighted average exercise price, Vested and expected to vest \| $ / shares	$ 9.88

XML 39 R27.htm IDEA: XBRL DOCUMENT

Equity Incentive Plans - Schedule of RSU's (Details) - RSUs	6 Months Ended
	Jun. 30, 2017 $ / shares shares
Number of RSUs
Number of RSUs, granted \| shares	1,661,619
Number of RSUs, unvested at ending of year \| shares	1,661,619
Weighted average grant date fair value price
Weighted average grant date date fair value price, granted \| $ / shares	$ 9.64
Weighted average grant date date fair value price, unvested at ending of year \| $ / shares	$ 9.64

XML 40 R28.htm IDEA: XBRL DOCUMENT

Equity Incentive Plans - Schedule of Fair Value of Equity Based Awards Using Black-Scholes Option Pricing Model (Details)	6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (years)		6 years 3 months	6 years 3 months
Expected volatility, minimum	56.74%	59.80%	58.40%
Expected volatility, maximum	59.15%	61.65%	61.70%
Risk-free interest rate, minimum	1.99%	1.23%	1.23%
Risk-free interest rate, maximum	2.23%	1.88%	1.88%
Dividend yield	0.00%	0.00%	0.00%
Options \| Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (years)	5 years 6 months
Options \| Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (years)	6 years 3 months
ESPP
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (years)	6 months		5 months 1 day
Expected volatility	82.00%		70.45%
Risk-free interest rate	0.62%		0.40%
Dividend yield	0.00%		0.00%

XML 41 R29.htm IDEA: XBRL DOCUMENT

Equity Incentive Plans - Schedule of Non-cash Share-Based Compensation Expenses Related to Company's Equity-Based Awards (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	$ 7,570	$ 5,637	$ 12,131	$ 11,093	$ 21,441
Cost of Revenues
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	131	170	274	311	623
Research, Development and Clinical Trials
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	811	839	1,673	1,602	3,155
Sales and Marketing
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	1,735	1,349	2,390	2,639	5,111
General and Administrative
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total share-based compensation expense	$ 4,893	$ 3,279	$ 7,794	$ 6,541	$ 12,552

XML 42 R30.htm IDEA: XBRL DOCUMENT

Supplemental Information - Schedule of Long-Lived Assets by Location (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Revenues From External Customers And Long Lived Assets [Line Items]
Long-lived assets	$ 18,682	$ 18,620
United States
Revenues From External Customers And Long Lived Assets [Line Items]
Long-lived assets	12,096	11,981
Switzerland
Revenues From External Customers And Long Lived Assets [Line Items]
Long-lived assets	4,358	4,346
Israel
Revenues From External Customers And Long Lived Assets [Line Items]
Long-lived assets	1,777	1,915
Others
Revenues From External Customers And Long Lived Assets [Line Items]
Long-lived assets	$ 451	$ 378

XML 43 R31.htm IDEA: XBRL DOCUMENT

Supplemental Information - Schedule of Revenues by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenues	$ 38,376	$ 17,919	$ 73,256	$ 30,972	$ 82,888
United States
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenues	31,367	16,122	60,526	28,135	72,771
EMEA
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenues	6,891	$ 1,797	12,559	2,775	10,028
Japan
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenues	$ 118		$ 171	$ 62	$ 89

XML 44 R32.htm IDEA: XBRL DOCUMENT

Supplemental Information - Schedule of Revenues by Geographic Region (Parenthetical) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenues	$ 38,376	$ 17,919	$ 73,256	$ 30,972	$ 82,888
Germany
Revenues From External Customers And Long Lived Assets [Line Items]
Net revenues	$ 6,817	$ 1,766	$ 12,216	$ 2,659	$ 9,799

EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end

XML 46 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 98 160 1 false 25 0 false 4 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.novocure.com/20170630/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.novocure.com/20170630/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 100020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.novocure.com/20170630/taxonomy/role/StatementCONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.novocure.com/20170630/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 100040 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://www.novocure.com/20170630/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Statements 5 false false R6.htm 100050 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Sheet http://www.novocure.com/20170630/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Statements 6 false false R7.htm 100060 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) Sheet http://www.novocure.com/20170630/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.novocure.com/20170630/taxonomy/role/StatementCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 100080 - Disclosure - Organization and Basis of Presentation Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureOrganizationAndBasisOfPresentation Organization and Basis of Presentation Notes 9 false false R10.htm 100090 - Disclosure - Short-Term Investments Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureShortTermInvestments Short-Term Investments Notes 10 false false R11.htm 100100 - Disclosure - Inventories Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureInventories Inventories Notes 11 false false R12.htm 100110 - Disclosure - Commitments and Contingent Liabilities Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureCommitmentsAndContingentLiabilities Commitments and Contingent Liabilities Notes 12 false false R13.htm 100120 - Disclosure - Share Capital Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureShareCapital Share Capital Notes 13 false false R14.htm 100130 - Disclosure - Equity Incentive Plans Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureEquityIncentivePlans Equity Incentive Plans Notes 14 false false R15.htm 100140 - Disclosure - Supplemental Information Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureSupplementalInformation Supplemental Information Notes 15 false false R16.htm 100150 - Disclosure - Organization and Basis of Presentation (Policies) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationPolicies Organization and Basis of Presentation (Policies) Policies 16 false false R17.htm 100160 - Disclosure - Inventories (Tables) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureInventoriesTables Inventories (Tables) Tables http://www.novocure.com/20170630/taxonomy/role/DisclosureInventories 17 false false R18.htm 100170 - Disclosure - Equity Incentive Plans (Tables) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureEquityIncentivePlansTables Equity Incentive Plans (Tables) Tables http://www.novocure.com/20170630/taxonomy/role/DisclosureEquityIncentivePlans 18 false false R19.htm 100180 - Disclosure - Supplemental Information (Tables) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureSupplementalInformationTables Supplemental Information (Tables) Tables http://www.novocure.com/20170630/taxonomy/role/DisclosureSupplementalInformation 19 false false R20.htm 100190 - Disclosure - Organization and Basis of Presentation - Additional Information (Detail) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetail Organization and Basis of Presentation - Additional Information (Detail) Details 20 false false R21.htm 100200 - Disclosure - Short-Term Investments - Additional Information (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureShortTermInvestmentsAdditionalInformationDetails Short-Term Investments - Additional Information (Details) Details 21 false false R22.htm 100210 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails Inventories - Schedule of Inventories (Details) Details 22 false false R23.htm 100220 - Disclosure - Commitments and Contingent Liabilities - Additional Information (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureCommitmentsAndContingentLiabilitiesAdditionalInformationDetails Commitments and Contingent Liabilities - Additional Information (Details) Details 23 false false R24.htm 100230 - Disclosure - Share Capital - Additional Information (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureShareCapitalAdditionalInformationDetails Share Capital - Additional Information (Details) Details 24 false false R25.htm 100240 - Disclosure - Equity Incentive Plans - Additional Information (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureEquityIncentivePlansAdditionalInformationDetails Equity Incentive Plans - Additional Information (Details) Details 25 false false R26.htm 100250 - Disclosure - Equity Incentive Plans - Schedule of Stock Option Plan (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureEquityIncentivePlansScheduleOfStockOptionPlanDetails Equity Incentive Plans - Schedule of Stock Option Plan (Details) Details 26 false false R27.htm 100260 - Disclosure - Equity Incentive Plans - Schedule of RSU's (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureEquityIncentivePlansScheduleOfRSUSDetails Equity Incentive Plans - Schedule of RSU's (Details) Details 27 false false R28.htm 100270 - Disclosure - Equity Incentive Plans - Schedule of Fair Value of Equity Based Awards Using Black-Scholes Option Pricing Model (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureEquityIncentivePlansScheduleOfFairValueOfEquityBasedAwardsUsingBlackScholesOptionPricingModelDetails Equity Incentive Plans - Schedule of Fair Value of Equity Based Awards Using Black-Scholes Option Pricing Model (Details) Details 28 false false R29.htm 100280 - Disclosure - Equity Incentive Plans - Schedule of Non-cash Share-Based Compensation Expenses Related to Company's Equity-Based Awards (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureEquityIncentivePlansScheduleOfNonCashShareBasedCompensationExpensesRelatedToCompanySEquityBasedAwardsDetails Equity Incentive Plans - Schedule of Non-cash Share-Based Compensation Expenses Related to Company's Equity-Based Awards (Details) Details 29 false false R30.htm 100290 - Disclosure - Supplemental Information - Schedule of Long-Lived Assets by Location (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureSupplementalInformationScheduleOfLongLivedAssetsByLocationDetails Supplemental Information - Schedule of Long-Lived Assets by Location (Details) Details 30 false false R31.htm 100300 - Disclosure - Supplemental Information - Schedule of Revenues by Geographic Region (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureSupplementalInformationScheduleOfRevenuesByGeographicRegionDetails Supplemental Information - Schedule of Revenues by Geographic Region (Details) Details 31 false false R32.htm 100310 - Disclosure - Supplemental Information - Schedule of Revenues by Geographic Region (Parenthetical) (Details) Sheet http://www.novocure.com/20170630/taxonomy/role/DisclosureSupplementalInformationScheduleOfRevenuesByGeographicRegionParentheticalDetails Supplemental Information - Schedule of Revenues by Geographic Region (Parenthetical) (Details) Details 32 false false All Reports Book All Reports nvcr-20170630.xml nvcr-20170630.xsd nvcr-20170630_cal.xml nvcr-20170630_def.xml nvcr-20170630_lab.xml nvcr-20170630_pre.xml true true ZIP 51 0001564590-17-014164-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-17-014164-xbrl.zip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�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�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end